Department of Urology

488  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Fujiwara Motohiro, Yoshida Soichiro, Yajima Shugo, Tanabe Kenji, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis. Clin Genitourin Cancer. 2026.08; 24 (5): 102566. ( PubMed , DOI )

  2. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer. Urol Oncol. 2026.08; 44 (8): 120-126. ( PubMed , DOI )

  3. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: Bayesian Secondary Reanalysis of Published Aggregate Data on Circulating Tumor DNA for Molecular Residual Disease Detection Across Cancer Types. Ann Clin Biochem. 2026.07; 45632261475618. ( PubMed , DOI )

  4. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial. Int J Urol. 2026.07; 33 (7): e70582. ( PubMed , DOI )

  5. Chen Wei, Yoshida Soichiro, Yajima Shugo, Fukushima Hiroshi, Sato Hiroyuki, Hirakawa Akihiro, Yamamoto Takanobu, Honda Hiroyuki, Matsuo Tomohiro, Wada Naoki, Masuda Hitoshi, Fujii Yasuhisa: Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study. Urology. 2026.07; ( PubMed , DOI )

  6. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data. Low Urin Tract Symptoms. 2026.07; 18 (4): e70083. ( PubMed , DOI )

  7. Fujiwara Motohiro, Yoshida Soichiro, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Arita Yuki, Tanaka Hajime, Yokoyama Minato, Masuda Hitoshi, Fujii Yasuhisa: Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs. Sunitinib) for Advanced Renal Cell Carcinoma. Anticancer Res. 2026.07; 46 (7): 3889-3896. ( PubMed , DOI )

  8. Yajima Shugo, Yoshida Soichiro, Imasato Naoki, Chen Wei, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysis. Urol Oncol. 2026.07; ( PubMed , DOI )

  9. Ishikawa Yudai, Tanaka Hajime, Yamaguchi Yoshitomo, Maruyama Riko, Fukuda Shohei, Waseda Yuma, Inoue Masaharu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Fujii Yasuhisa: Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications. Int J Urol. 2026.07; 33 (7): e70571. ( PubMed , DOI )

  10. Yasuda Yosuke, Yoshida Soichiro, Ikeda Sadakatsu, Yonese Ichiro, Sano Yuta, Urasaki Tetsuya, Nakamura Yuki, Tanaka Hajime, Ito Masaya, Miura Yuji, Numao Noboru, Matsuoka Yoh, Koga Fumitaka, Yonese Junji, Fujii Yasuhisa: Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer. Jpn J Clin Oncol. 2026.07; 56 (7): 879-884. ( PubMed , DOI )

  11. Yonese Ichiro, Koga Fumitaka, Toide Masahiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Fujiwara Motohiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04). Jpn J Clin Oncol. 2026.07; 56 (7): 885-893. ( PubMed , DOI )

  12. Chen W, Yoshida S, Yajima S, Sato H, Hirakawa A, Fujii Y.: Quantifying benefit of adding docetaxel to androgen receptor-axis therapy in metastatic hormone-sensitive prostate cancer with Bayesian analysis. IInternational Urology and Nephrology. 2026.07; 58 (7): 2609-2611. ( PubMed , DOI )

  13. Yajima Shugo, Yoshida Soichiro, Imasato Naoki, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Postoperative Management After Pathological Complete Response to Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer: An Exploratory Reconstructed Individual Patient Data Analysis. Clin Genitourin Cancer. 2026.06; 24 (6): 102603. ( PubMed , DOI )

  14. Chen Wei, Yoshida Soichiro, Yajima Shugo, Fujiwara Motohiro, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Fujii Yasuhisa: Bayesian re-analysis of ERA223 and PEACE-3 temporal dynamics and bone protection in radium-223-treated metastatic castration-resistant prostate cancer. Jpn J Clin Oncol. 2026.06; ( PubMed , DOI )

  15. Yajima Shugo, Yoshida Soichiro, Fukuda Shohei, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Matsuoka Yoh, Kageyama Yukio, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yonese Junji, Nakayama Akinori, Saito Kazutaka, Ito Masaya, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa: Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects. Int J Urol. 2026.06; 33 (6): e70536. ( PubMed , DOI )

  16. Yajima Shugo, Yoshida Soichiro, Fujii Yasuhisa: Beyond Discrimination Metrics: A Bayesian Reinterpretation of S2,3PSA% for Individual Patient Counseling. Eur Urol Open Sci. 2026.06; 88 9-10. ( PubMed , DOI )

  17. Yasuda Yosuke, Yoshida Soichiro, Yajima Shugo, Yamaguchi Yoshitomo, Chen Wei, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Suzuki Kotaro, Ishihara Kensaku, Yonese Ichiro, Tamiya Takashi, Izumi Keita, Yamamoto Takanobu, Nakamura Yuki, Uehara Sho, Toide Masahiro, Araki Saori, Kawamura Naoko, Asano Touko, Takazawa Ryoji, Numao Noboru, Fujii Yasuhisa: Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis. Prostate. 2026.06; 86 (8): 911-919. ( PubMed , DOI )

  18. Yajima Shugo, Yoshida Soichiro, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Nakamura Yuki, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Masuda Hitoshi, Fujii Yasuhisa: Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis(タイトル和訳中) Japanese Journal of Clinical Oncology. 2026.05; 56 (5): 636-645. ( ichushi )

  19. Shimoda Hiroki, Nakamura Yuki, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study(タイトル和訳中) International Journal of Urology. 2026.05; 33 (5): iju.70486. ( ichushi )

  20. Yajima Shugo, Yoshida Soichiro, Masuda Hitoshi, Fujii Yasuhisa: Rethinking survival visualisation: moving beyond Kaplan-Meier curves and hazard ratios in urology. Transl Androl Urol. 2026.05; 15 (5): 188. ( PubMed , DOI )

  21. Yajima Shugo, Yoshida Soichiro, Masuda Hitoshi, Fujii Yasuhisa: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: exploratory analysis of the proportional hazards assumption. Transl Androl Urol. 2026.05; 15 (5): 189. ( PubMed , DOI )

  22. Fukushima Hiroshi, Yoshida Soichiro, Fujii Yasuhisa: From trial results to bedside decisions: a time-resolved view of CheckMate-9ER. Transl Androl Urol. 2026.05; 15 (5): 148. ( PubMed , DOI )

  23. Fukushima Hiroshi, Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment on Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma. Int J Urol. 2026.05; 33 (5): e70480. ( PubMed , DOI )

  24. Shimoda Hiroki, Nakamura Yuki, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Fukushima Hiroshi, Fukuda Shohei, Yuma Waseda, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study. Int J Urol. 2026.05; 33 (5): e70486. ( PubMed , DOI )

  25. Kobayashi Masaki, Matsuoka Yoh, Kimura Koichiro, Matsumoto Shunya, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsy. Urol Oncol. 2026.05; 44 (5): 111081. ( PubMed , DOI )

  26. Yajima S, Yoshida S, Chen W, Sato H, Hirakawa A, Fukushima H, Nakamura Y, Tanaka H, Inoue M, Numao N, Yoshinaga A, Kawamura N, Yonose I, Izumi K, Yamamoto T, Uehara S, Suzuki K, Toide M, Takazawa R, Araki S, Masuda H, Fujii Y.: Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis. Japanese Journal of Clinical Oncology. 2026.05; 56 (5): 636-645. ( PubMed , DOI )

  27. Sekiguchi Y, Mori M, Maruyama H, Nakao Y, Kikuchi H, Mandai S, Ando F, Susa K, Mori T, Waseda Y, Yoshida S, Fujii Y, Shoda W, Takahashi D, Okazaki R, Ikeda K, Yamada T, Sohara E, Uchida S, Mori Y: The Pathophysiological Mechanism of Beni-koji Choleste-Help or Puberulic Acid-Induced Kidney Injury. Kidney international reports. 2026.04; 11 (4): 103793. ( PubMed , DOI )

  28. Hirose Kohei, Yoshida Soichiro, Chen Wei, Yajima Shugo, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer(タイトル和訳中) Japanese Journal of Clinical Oncology. 2026.04; 56 (4): 484-488. ( ichushi )

  29. Chen Wei, Yoshida Soichiro, Hirakawa Akihiro, Sato Hiroyuki, Yajima Shugo, Kobayashi Masaki, Fujiwara Motohiro, Fukushima Hiroshi, Arita Yuki, Waseda Yuma, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial(タイトル和訳中) Japanese Journal of Clinical Oncology. 2026.04; 56 (4): 455-460. ( ichushi )

  30. Muta Rie, Fukushima Hiroshi, Tanaka Hajime, Numao Noboru, Nakamura Yuki, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Yoshida Soichiro, Fujii Yasuhisa: Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study(YUSHIMA Study)(タイトル和訳中) International Journal of Urology. 2026.04; 33 (4): iju.70459. ( ichushi )

  31. Fukushima Hiroshi, Yoshida Soichiro, Yajima Shugo, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fujiwara Motohiro, Arita Yuki, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101. JCO Clin Cancer Inform. 2026.04; 10 (2): e2500307. ( PubMed , DOI )

  32. Hirose Kohei, Yoshida Soichiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer. Jpn J Clin Oncol. 2026.04; ( PubMed , DOI )

  33. Yajima Shugo, Yoshida Soichiro, Fukuda Shohei, Chen Wei, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Matsuoka Yoh, Kageyama Yukio, Tanaka Hajime, Inoue Masaharu, Numao Noboru, Yonese Junji, Nakayama Akinori, Saito Kazutaka, Ito Masaya, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa: External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinations. Int Urol Nephrol. 2026.04; ( PubMed , DOI )

  34. Tanabe Kenji, Yoshida Soichiro, Fujiwara Motohiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: Reanalysis of LUNAR progression-free survival using reconstructed individual patient data: time-varying treatment effects. Int Urol Nephrol. 2026.04; ( PubMed , DOI )

  35. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Fukuda Shohei, Tanaka Hajime, Sato Hiroyuki, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: Probabilistic multi-criteria decision analysis comparing single-port and multiport robot-assisted radical prostatectomy and partial nephrectomy: A secondary analysis of systematic review data. J Robot Surg. 2026.04; 20 (1): ( PubMed , DOI )

  36. Muta Rie, Fukushima Hiroshi, Tanaka Hajime, Numao Noboru, Nakamura Yuki, Yoshinaga Atsushi, Kawamura Naoko, Yonese Ichiro, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Suzuki Kotaro, Toide Masahiro, Takazawa Ryoji, Araki Saori, Yoshida Soichiro, Fujii Yasuhisa: Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study). Int J Urol. 2026.04; 33 (4): e70459. ( PubMed , DOI )

  37. Fukushima Hiroshi, Yoshida Soichiro, Hirakawa Akihiro, Yasuda Yosuke, Miura Yuji, Fujii Yasuhisa: Bayesian interpretation of febrile neutropenia risk and primary granulocyte colony-stimulating factor prophylaxis during darolutamide triplet therapy. Jpn J Clin Oncol. 2026.04; ( PubMed , DOI )

  38. Chen Wei, Fukuda Shohei, Yoshida Soichiro, Kobayashi Nao, Fukada Kyohei, Fukunishi Munenori, Otani Yuhi, Fukushima Hiroshi, Yasuda Yosuke, Fu Guangqing, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa: Human-in-the-loop validation of an artificial intelligence-driven real-time prostatic capsule recognition model for nerve-sparing robot-assisted radical prostatectomy. Surg Endosc. 2026.04; 40 (4): 3501-3509. ( PubMed , DOI )

  39. Hirose K, Yoshida S, Chen W, Yajima S, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.: Bayesian reanalysis to assess consistency of TALAPRO-2 results in the Japanese subgroup with metastatic castration-resistant prostate cancer. Japanese Journal of Clinical Oncology. 2026.04; 56 (4): 484-488. ( PubMed , DOI )

  40. Chen W, Yoshida S, Yajima S, Sato H, Hirakawa A, Tanabe K, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.: Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysis. Urologic Oncology. 2026.04; 44 (4): 110990. ( PubMed , DOI )

  41. Shimoda Hiroki, Fukuda Shohei, Yafuso Daiki, Yamamoto Kouhei, Ishikawa Yudai, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report(タイトル和訳中) IJU Case Reports. 2026.03; 9 (2): iju5.70170. ( ichushi )

  42. Shimoda Hiroki, Fukuda Shohei, Yafuso Daiki, Yamamoto Kouhei, Ishikawa Yudai, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report. IJU Case Rep. 2026.03; 9 (2): e70170. ( PubMed , DOI )

  43. Yajima S, Chen W, Hirose K, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Tanaka H, Masuda H, Fujii Y, Yoshida S.: Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysis. European Urology Open Science. 2026.03; 85 60-70. ( PubMed , DOI )

  44. Matsumoto S, Yoshida S, Yajima S, Sato H, Hirakawa A, Fujiwara M, Fukushima H, Yasuda Y, Waseda Y, Tanaka H, Yokoyama M, Masuda H, Fujii Y. : A probabilistic multicriteria decision analysis of robot-assisted versus laparoscopic sacrocolpopexy: a secondary analysis of published meta-analytic data. Journal of Robotic Surgery. 2026.03; 20 (1): ( PubMed , DOI )

  45. Yajima S, Yoshida S, Chen W, Hirose K, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Tanaka H, Masuda H, Fujii Y. : Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trial. Japanese Journal of Clinical Oncology. 2026.02; 56 (2): 216-220. ( PubMed , DOI )

  46. Yajima Shugo, Yoshida Soichiro, Chen Wei, Fukushima Hiroshi, Masuda Hitoshi, Fujii Yasuhisa: Comparison of Perioperative Chemotherapy Regimens for Muscle-Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials. Int J Urol. 2026.02; 33 (2): e70380. ( PubMed , DOI )

  47. Tanabe Kenji, Yoshida Soichiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: ARASENS試験における臨床的純利益のベイズ多基準意思決定分析　全体および日本人サブグループの結果(Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup Results) International Journal of Urology. 2026.02; 33 (2): iju.70384. ( ichushi )

  48. Chen Wei, Yoshida Soichiro, Fujii Yasuhisa: Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison. Cancer Rep (Hoboken). 2026.02; 9 (2): e70496. ( PubMed , DOI )

  49. Chen Wei, Yoshida Soichiro, Yajima Shugo, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa: 転移性去勢抵抗性前立腺癌のエンザルタミド+ラジウム223併用療法による生存に対する遅延効果　PEACE-3試験の再構築患者データを用いた時間依存性解析(Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial) International Journal of Urology. 2026.02; 33 (2): iju.70376. ( ichushi )

  50. Yajima Shugo, Yoshida Soichiro, Chen Wei, Hirose Kohei, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa: 進行性尿路上皮癌のアジア人および日本人患者におけるアベルマブ維持療法のベイズ再解析　JAVELIN Bladder 100試験からのエビデンス(Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trial) Japanese Journal of Clinical Oncology. 2026.02; 56 (2): 216-220. ( ichushi )

  51. Fukushima H, Yajima H, Sato H, Hirakawa A, Yoshida S, Fujii Y. : Bayesian Re-Interpretation of the CheckMate-9ER Final Analysis: Organ-Site and IMDC Risk-Stratified Probabilities of Benefit. International Journal of Urology. 2026.02; 33 (2): e70379. ( PubMed , DOI )

  52. Tanabe K, Yoshida S, Chen W, Yajima S, Sato H, Hirakawa A, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.: Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup Results. International Journal of Urology. 2026.02; 33 (2): e70384. ( PubMed , DOI )

  53. Fukushima H, Yoshida S, Yajima S, Chen W, Sato H, Hirakawa A, Fujiwara M, Arita Y, Yasuda Y, Tanaka H, Morizane S, Yokoyama M, Masuda H, Takenaka A, Fujii Y.: A multi‑criteria decision analysis comparing robot‑assisted, laparoscopic, and open radical cystectomy using large-scale Japanese nationwide databases. Journal of Robotic Surgery. 2026.02; 20 (1): 230. ( PubMed , DOI )

  54. Chen W, Yoshida S, Yajima S, Tanabe K, Fujiwara M, Fukushima H, Tanaka H, Hirakawa A, Masuda H, Fujii Y.: Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial. International Journal of Urology. 2026.02; 33 (2): e70376. ( PubMed , DOI )

  55. Yajima S, Yoshida S, Fukushima H, Hirakawa A, Masuda H, Fujii Y.: Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial. International Journal of Urology. 2026.01; 33 (1): e70256. ( PubMed , DOI )

  56. Soma Takahiko, Tanaka Hajime, Nakamura Yuki, Numao Noboru, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Tanabe Kenji, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Maezawa Yuya, Toide Masahiro, Takazawa Ryoji, Araki Saori, Kitabayashi Ryo, Hirakawa Akihiro, Yoshida Soichiro, Koga Fumitaka, Fujii Yasuhisa: Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study(YUSHIMA Study)(タイトル和訳中) International Journal of Urology. 2026.01; 33 (1): iju.70329. ( ichushi )

  57. Ishikawa Yudai, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa: Bladder region-specific analysis of the diagnostic performance of oral 5-aminolevulinic acid fluorescence cystoscopy in non-muscle-invasive bladder cancer. Jpn J Clin Oncol. 2026.01; 56 (1): 97-103. ( PubMed , DOI )

  58. Tanaka Hiroki, Kobayashi Masaki, Matsumoto Shunya, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Impact of Approach Routes in MRI-Ultrasound Fusion Prostate Biopsy on Post-Biopsy Complications: A Propensity Score-Matched Analysis. Int J Urol. 2026.01; 33 (1): e70275. ( PubMed , DOI )

  59. Chen Wei, Yoshida Soichiro, Ikeda Riko, Yoshimura Ryoichi, Fujii Yasuhisa: Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review. Int J Urol. 2026.01; 33 (1): e70324. ( PubMed , DOI )

  60. Tanaka Hiroki, Kobayashi Masaki, Matsumoto Shunya, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: Impact of Approach Routes in MRI-Ultrasound Fusion Prostate Biopsy on Post-Biopsy on Post-Biopsy Complications: A Propensity Score-Matched Analysis(タイトル和訳中) International Journal of Urology. 2026.01; 33 (1): iju.70275. ( ichushi )

  61. Pyrgidis Nikolaos, Schulz Gerald Bastian, Scilipoti Pietro, Pellegrino Francesco, Casuscelli Jozefina, Tzelves Lazaros, Katsimperis Stamatios, Ciavarella Davide, Mir Maria Carmen, Sokolakis Ioannis, Klatte Tobias, Belinchon Alberto Ramos, Velasco Jorge Caño, Fujii Yasuhisa, Tanaka Hajime, Yoshida Soichiro, Matsumoto Shunya, Umari Paolo, Teoh Jeremy Yuen-Chun, Ming Chris Wong Ho, Simone Giuseppe, Mastroianni Riccardo, Mayr Roman, Giudice Francesco Del, Moschini Marco: The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis. Eur Urol Focus. 2026.01; 12 (1): 88-95. ( PubMed , DOI )

  62. Arita Yuki, Edo Hiromi, Yoshida Soichiro: Structured MRI assessment after neoadjuvant therapy for bladder cancer: the emerging roles of NacVI-RADS and multimodal AI. Eur Radiol. 2026.01; 36 (1): 229-231. ( PubMed , DOI )

  63. Yasuda Yosuke, Yoshida Soichiro, Matsubara Daigoro, Takahara Taro, Yoshimura Ryoichi, Fujii Yasuhisa: Outcomes and Safety Profile of Repeated Progressive Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant Prostate Cancer. Int J Urol. 2026.01; 33 (1): e70253. ( PubMed , DOI )

  64. Ishikawa Yudai, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa: 筋層非浸潤性膀胱癌における経口5-アミノレブリン酸蛍光膀胱鏡検査の診断性能に関する膀胱部位特異的解析(Bladder region-specific analysis of the diagnostic performance of oral 5-aminolevulinic acid fluorescence cystoscopy in non-muscle-invasive bladder cancer) Japanese Journal of Clinical Oncology. 2026.01; 56 (1): 97-103. ( ichushi )

  65. Yasuda Y, Yoshida S, Yajima S, Fukushima H, Hirakawa A, Fujii Y.: Bayesian Reanalysis of Adjuvant Nivolumab in Japanese Patients With High-Risk Muscle-Invasive Urothelial Carcinoma. International Journal of Urology. 2026.01; 33 (1): e70305. ( PubMed , DOI )

  66. Yajima S, Yoshida S, Chen W, Sato H, Hirakawa A, Fujiwara M, Yokoyama M, Arita Y, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y.: Probabilistic multi-criteria decision analysis comparing robot-assisted and laparoscopic radical nephroureterectomy. Journal of Robotics Surgery. 2026.01; 20 (1): 162. ( PubMed , DOI )

  67. Fukushima H, Yajima S, Chen W, Hirakawa A, Tanabe K, Fujiwara M, Arita Y, Tanaka H, Masuda H, Fujii Y, Yoshida S.: Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis. Targeted Oncology. 2026.01; 21 (1): 1-12. ( PubMed , DOI )

  68. Tanabe K, Yoshida S, Chen A, Yajima S, Hirakawa A, Fujii Y.: Non-Proportional Hazards Analysis of the RADIOSA Trial Using Reconstructed Individual Patient Data. International Journal of Urology. 2026.01; 33 (1): e70354. ( PubMed , DOI )

  69. Soma T, Tanaka H, Nakamura Y, Numao N, Inoue M, Yoshinaga A, Kawamura N, Tanabe K, Izumi K, Yamamoto T, Uehara S, Maezawa Y, Toide M, Takazawa R, Araki S, Kitabayashi R, Hirakawa A, Yoshida S, Koga F, Fujii Y.: Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study). International Journal of Urology. 2026.01; 33 (1): e70329. ( PubMed , DOI )

  70. Ryo Kaneda, Masanori Murakami, Akiko Hirano, Airi Nakayama, Satoru Uchida, Kazutaka Tsujimoto, Chikara Komiya, Kenji Ikeda, Hiroki Fujiwara, Toshikage Nagao, Soichiro Yoshida, Yasuhisa Fujii, Tetsuya Yamada: A case of immune thrombocytopenia aggravated by therapy for hypercortisolism in adrenocortical carcinoma. Ther Adv Endocrinol Metab. 2026; 17 20420188261419209. ( PubMed , DOI )

  1. Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima, Hiroyuki Sato, Akihiro Hirakawa, Yasuhisa Fujii: Restricted mean survival time comparison of olaparib plus abiraterone versus talazoparib plus enzalutamide in first-line metastatic castration-resistant prostate cancer: indirect analyses of propel and talapro-2. Int Urol Nephrol. 2025.12; ( PubMed , DOI )

  2. Margaret F Meagher, Giacomo Musso, Viraj Master, Hajime Tanaka, Umberto Capitanio, Allesandro Larcher, Mai Dabbas, Dattatraya Patil, Wei Chen, Dhruv Puri, Benjamin H Baker, Shamsunnahar Imtiaz, Cesare Saitta, Shohei Fukuda, Masaki Kobayashi, Andrea Salonia, Alberto Briganti, Yasuhisa Fujii, Francesco Montorsi, Ithaar H Derweesh: Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system. Urol Oncol. 2025.12; 43 (12): 706.e1-706.e10. ( PubMed , DOI )

  3. Hiroshi Fukushima, Yuki Nakamura, Hajime Tanaka, Noboru Numao, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii: Impact of Impaired Renal Function on the Efficacy and Safety of Enfortumab Vedotin Monotherapy in a Multicenter Real-World Cohort of Patients With Metastatic Urothelial Cancer: YUSHIMA Study. Clin Genitourin Cancer. 2025.12; 23 (6): 102426. ( PubMed , DOI )

  4. Wei Chen, Hajime Tanaka, Soichiro Yoshida, Shunya Matsumoto, Masaki Kobayashi, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Yasuhisa Fujii: Comparisons of Pembrolizumab Plus Lenvatinib, Nivolumab Plus Cabozantinib, and Cabozantinib Monotherapy in Advanced Non-Clear Cell Renal Cell Carcinoma Based on Individual Patient Data Reconstruction. Clin Genitourin Cancer. 2025.12; 23 (6): 102458. ( PubMed , DOI )

  5. Wei Chen, Soichiro Yoshida, Akihiro Hirakawa, Hiroyuki Sato, Shugo Yajima, Masaki Kobayashi, Motohiro Fujiwara, Hiroshi Fukushima, Yuki Arita, Yuma Waseda, Hajime Tanaka, Hitoshi Masuda, Yasuhisa Fujii: Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial. Jpn J Clin Oncol. 2025.12; ( PubMed , DOI )

  6. Wei Chen, Soichiro Yoshida, Koichiro Kimura, Yuki Arita, Yasuhisa Fujii: Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial. Eur Urol Focus. 2025.12; ( PubMed , DOI )

  7. Tetsuya Wako, Go Kimura, Yasuhisa Fujii, Takahiro Osawa, Yosuke Uchitomi, Kazunori Honda, Miki Kondo, Ariko Otani, Yoshihide Mitsuda, Nobuo Shinohara: Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan. Cancers (Basel). 2025.12; 17 (24): ( PubMed , DOI )

  8. Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross, Andreas Røder, Andrea Juliana Gomes, Stephane Supiot, Philippe Barthélémy, Koji Hatano, Carmen Belen Congregado Ruiz, Soichiro Yoshida, Bernardo Herrera-Imbroda, Matthieu Gratton, Jürgen E Gschwend, Thomas A Hope, Heikki Joensuu, Iris Kuss, Marie-Aude Le Berre, Miryana Dimova-Dobreva, Karim Fizazi: Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP). Future Oncol. 2025.11; 21 (27): 3491-3498. ( PubMed , DOI )

  9. Yasuda Yosuke, Wang Zijie, Yoshida Soichiro, Chen Wei, Tanaka Hajime, Fujii Yasuhisa: PROpel試験とTALAPRO-2試験のShiny法を用いた間接比較　転移性去勢抵抗性前立腺癌における比較解析(Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer) International Journal of Urology. 2025.11; 32 (11): 1709-1711. ( ichushi )

  10. Giacomo Musso, Natalie Birouty, Andrea Salonia, Giuseppe Garofano, Mai Dabbas, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Cesare Saitta, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Alessandro Larcher, Giuseppe Rosiello, Yasuhisa Fujii, Viraj A Master, Ithaar H Derweesh: Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling. Urology. 2025.11; 205 99-107. ( PubMed , DOI )

  11. Soichiro Yoshida, Yosuke Yasuda, Yasuhisa Fujii: Editorial Comment to "Effects of Modifying Hinotori Surgical Robot System on the Surgical Step of the Dissection of the Renal Hilum and the Kidney Isolation". Int J Urol. 2025.11; 32 (11): 1707-1708. ( PubMed , DOI )

  12. Yosuke Yasuda, Zijie Wang, Soichiro Yoshida, Wei Chen, Hajime Tanaka, Yasuhisa Fujii: Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer. Int J Urol. 2025.11; 32 (11): 1709-1711. ( PubMed , DOI )

  13. Fujita Naoki, Matsushita Yuto, Kojima Takahiro, Bando Yukari, Osawa Takahiro, Sazuka Tomokazu, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Kawasaki Yoshihide, Kato Takuma, Miyake Makito, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kitamura Hiroshi, Miyake Hideaki, Hakakeyama Shingo: 転移性腎細胞癌一次免疫腫瘍併用療法後の二次チロシンキナーゼ阻害薬療法の有効性と安全性に対する腎機能障害の影響　日本の多施設共同後ろ向き研究(Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study) International Journal of Urology. 2025.10; 32 (10): 1506-1517. ( ichushi )

  14. Yuki Nakao, Makiko Mori, Yuta Sekiguchi, Iori Morita, Ryota Shindoh, Shintaro Mandai, Tamami Fujiki, Hiroaki Kikuchi, Fumiaki Ando, Koichiro Susa, Takayasu Mori, Ayumi Suzuki, Yuji Nashimoto, Hirokazu Kaji, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii, Eisei Sohara, Shinichi Uchida, Kensuke Miyake, Yutaro Mori: A Human Kidney Tubuloid Model of Repeated Cisplatin-Induced Cellular Senescence and Fibrosis for Drug Screening. Adv Healthc Mater. 2025.10; e01795. ( PubMed , DOI )

  15. Nonaka Daichi, Yoshida Soichiro, Nakano Kenta, Li Xiaojun, Okamura Tadashi, Umemoto Eiji, Yamada Taisho, Watanabe Miyuki, Jinno Shozo, Ito Minako, Tsuda Makoto, Noguchi Naoto, Jiang Jean X, Sumiya Eriko, Sawa Shinichiro: Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection. Mucosal Immunol. 2025.10; 18 (5): 1113-1123. ( PubMed , DOI )

  16. Kimura Tomoki, Fujiwara Motohiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 腎機能障害を伴う局所進行/転移性上部尿路上皮癌に対する一次治療の実診療成績(ゆしまSTUDY)(Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)) International Journal of Urology. 2025.10; 32 (10): 1369-1378. ( ichushi )

  17. Yasuda Yosuke, Numao Noboru, Matsumoto Shunya, Tamiya Takashi, Nakamura Yuki, Tanaka Hajime, Yoshida Soichiro, Kobayashi Shuichiro, Takazawa Ryoji, Matsuoka Yoh, Yonese Junji, Fujii Yasuhisa: 転移性ホルモン感受性前立腺癌患者における3剤併用療法の有効性と安全性に関する予備報告　ゆしまStudy(Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study) International Journal of Urology. 2025.10; 32 (10): 1413-1418. ( ichushi )

  18. Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study). Int J Urol. 2025.10; 32 (10): 1369-1378. ( PubMed , DOI )

  19. Yosuke Yasuda, Noboru Numao, Shunya Matsumoto, Takashi Tamiya, Yuki Nakamura, Hajime Tanaka, Soichiro Yoshida, Shuichiro Kobayashi, Ryoji Takazawa, Yoh Matsuoka, Junji Yonese, Yasuhisa Fujii: Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study. Int J Urol. 2025.10; 32 (10): 1413-1418. ( PubMed , DOI )

  20. Shunya Matsumoto, Yuma Waseda, Masaki Kobayashi, Yuki Nakamura, Yudai Ishikawa, Hiroshi Fukushima, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Incidence of Low-risk Upper Tract Urothelial Carcinoma in Candidates for Kidney-sparing Surgery. Anticancer Res. 2025.10; 45 (10): 4333-4341. ( PubMed , DOI )

  21. Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, Mattia Longoni, Alfonso Santangelo, José Daniel Subiela, Roberto Contieri, Luca Afferi, Stefania Zamboni, Nazareno Suardi, Gennaro Musi, Stefano Luzzago, David D'Andrea, Ekaterina Laukhtina, Francesco Soria, Paolo Gontero, Francesco Del Giudice, Muhammad Shamim Khan, Ramesh Thurairaja, Morgan Roupret, Elisabeth Grobet-Jeandin, Arthur Baudewyns, Hajime Tanaka, Shunya Matsumoto, Yasuhisa Fujii, Flavia Proietti, Giuseppe Simone, Gerald Bastian Schulz, Nicolaos Pyrgidis, Guillaume Ploussard, Alessandro Antonelli, Riccardo Bertolo, Mathieu Roumiguie, Anne-Sophie Bajeot, Maria Carme Mir, Paolo Umari, Jeremy Teoh, Chris Wong, Laura S Mertens, Renate Pichler, Keiichiro Mori, Aleksander Ślusarczyk, Cédric Poyet, Simone Albisinni, Atiqullah Aziz, Alessandro Volpe, Shahrokh Shariat, Benjamin Pradere, Pierre Karakiewicz, Stefano Resca, Edoardo Beatrici, Ruben De Groote, Alexandre Mottrie, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Marco Moschini, : Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study. World J Urol. 2025.10; 43 (1): 636. ( PubMed , DOI )

  22. Cesare Saitta, Giacomo Musso, Giuseppe Garofano, Hajime Tanaka, Dattatraya Patil, Margaret F Meagher, Srinivas Vourganti, Edward Cherullo, Michael Liss, Marco Paciotti, Giovanni Lughezzani, Nicolò M Buffi, Viraj Master, Yasuhisa Fujii, Rana R McKay, Ithaar H Derweesh: Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers (Basel). 2025.10; 17 (21): ( PubMed , DOI )

  23. Naoki Fujita, Yuto Matsushita, Takahiro Kojima, Yukari Bando, Takahiro Osawa, Tomokazu Sazuka, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Yoshihide Kawasaki, Takuma Kato, Makito Miyake, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Hiroshi Kitamura, Hideaki Miyake, Shingo Hakakeyama, : Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study. Int J Urol. 2025.10; 32 (10): 1506-1517. ( PubMed , DOI )

  24. Srisopitsawat Pavarut, Obi Takashi, Lee Joong-Sun, Tanaka Hajime, Matsuoka Yoh, Fuji Yasuhisa: 医用画像データ拡張に用いるStable Diffusionモデルを使用してのControlNet支援インペインティング法(ControlNet-Assisted Inpainting for Medical Image Augmentation Using Stable Diffusion Models) 日本医用画像工学会大会予稿集. 2025.08; 44回 289-290. ( ichushi )

  25. Tsuji Takumasa, Yoshida Soichiro, Hommyo Mitsuki, Oyama Asuka, Kumagai Shinobu, Shiraishi Kenshiro, Kotoku Jun'ichi: Cone Beam Computed Tomography Image-Quality Improvement Using "One-Shot" Super-resolution. J Imaging Inform Med. 2025.08; 38 (4): 2120-2133. ( PubMed , DOI )

  26. Giacomo Musso, Margaret F Meagher, Kit L Yuen, Benjamin Baker, Omer Baker, Aaron Ahdoot, Dhruv Puri, Mai Dabbas, Natalie Birouty, Cesare Saitta, Melis Guer, Dattatraya Patil, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Francesco Montorsi, Alberto Briganti, Andrea Salonia, Umberto Capitanio, Alessandro Larcher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinoma. Urol Oncol. 2025.08; 43 (8): 470.e1-470.e9. ( PubMed , DOI )

  27. Hara K, Murakami M, Shiba K, Tsujimoto K, Komiya C, Ikeda K, Yamamoto K, Taguchi T, Akashi T, Yoshida S, Ohashi K, Fujii Y, Yamada T.: Unexpected Remission of Bilateral Hyperaldosteronism After Unilateral Cortisol-Producing Adenoma Resection: A Report of Two Cases. Case Rep Endocrinol.. 2025.06; 9941688 ( PubMed )

  28. Yajima Shugo, Hata Shinro, Masumori Naoya, Matsuoka Yoh, Sawada Atsuro, Miki Jun, Tambo Mitsuhiro, Kobayashi Yasuyuki, Matsuda Ayumu, Nakane Keita, Kobayashi Takashi, Tanaka Hajime, Yamaguchi Noriya, Kaneko Go, Miller Russell, Seto Takehiro, Ito Hiroaki, Kikuchi Eiji: 筋層浸潤性膀胱癌における根治的膀胱全摘除術後の治療に関する患者の好み　日本における離散選択実験(Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan) International Journal of Urology. 2025.06; 32 (6): 688-697. ( ichushi )

  29. Tanabe Kenji, Yoshida Soichiro, Kimura Tomoki, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Fujii Yasuhisa: オリゴ転移型尿路上皮癌における予後因子および既存の予測モデルの効果(YUSHIMA研究)(Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)) International Journal of Clinical Oncology. 2025.06; 30 (6): 1237-1246. ( ichushi )

  30. Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii: Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study). Int J Clin Oncol. 2025.06; 30 (6): 1237-1246. ( PubMed , DOI )

  31. Cesare Saitta, Riccardo Autorino, Umberto Capitanio, Giovanni Lughezzani, Margaret F Meagher, Kendrick Yim, Mimi V Nguyen, Matilde Mantovani, Melis Guer, Daniele Amparore, Federico Piramide, Kevin Hakimi, Dattatraya Patil, Hajime Tanaka, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Savio D Pandolfo, Julian Cortes, Dhruv Puri, Kit Yuen, Massimo Lazzeri, Vittorio Fasulo, Alessandro Larcher, Marco Paciotti, Giuseppe Garofano, Francesco Porpiglia, Francesco Montorsi, Yasuhisa Fujii, Viraj Master, Nicolò M Buffi, Ithaar H Derweesh: Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102343. ( PubMed , DOI )

  32. Cesare Saitta, Giuseppe Garofano, Giacomo Musso, Hajime Tanaka, Dattatraya Patil, Vi Nguyen, Kit L Yuen, Benjamin Baker, Mai Dabbas, Margaret F Meagher, Dhruv Puri, Natalie Birouty, Omer Baker, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Giovanni Lughezzani, Alessandro Larcher, Umberto Capitanio, Riccardo Melloni, Mario Catanzaro, Sebastiano Nazzani, Nicola Nicolai, Yasuhisa Fujii, Viraj Master, Nicolòmaria Buffi, Ithaar H Derweesh: UNIK (Urologic Non-Neoplastic Investigation of Kidneys): a machine learning approach to decode benign lesion. World J Urol. 2025.06; 43 (1): 355. ( PubMed , DOI )

  33. Shugo Yajima, Shinro Hata, Naoya Masumori, Yoh Matsuoka, Atsuro Sawada, Jun Miki, Mitsuhiro Tambo, Yasuyuki Kobayashi, Ayumu Matsuda, Keita Nakane, Takashi Kobayashi, Hajime Tanaka, Noriya Yamaguchi, Go Kaneko, Russell Miller, Takehiro Seto, Hiroaki Ito, Eiji Kikuchi: Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan. Int J Urol. 2025.06; 32 (6): 688-697. ( PubMed , DOI )

  34. Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Shimpei Yamashita, Hisanori Taniguchi, Keisuke Monji, Ryo Ishiyama, Yoshihide Kawasaki, Takuma Kato, Shuichi Tatarano, Kimihiko Masui, Eijiro Nakamura, Tomoyuki Kaneko, Makito Miyake, Goshi Kitano, Takanobu Motoshima, Yusuke Shiraishi, Satoru Kira, Takaya Murashima, Hiroaki Hara, Masafumi Matsumura, Hiroshi Kitamura, Hideaki Miyake, Junya Furukawa, : Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102322. ( PubMed , DOI )

  35. Kikuchi Hiroshi, Osawa Takahiro, Matsushita Yuto, Kojima Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Ueda Kosuke, Tanaka Hajime, Kurahashi Toshifumi, Bando Yukari, Kimura Takahiro, Nishiyama Naotaka, Kato Takuma, Hara Hiroaki, Ito Yoichi, Kitamura Hiroshi, Miyake Hideaki, Shinohara Nobuo: 転移性腎細胞癌に対する一次治療のニボルマブ+イピリムマブ療法後にアキシチニブで治療された五つの予後モデルの検証　日本の多施設共同後ろ向き研究(Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study) Japanese Journal of Clinical Oncology. 2025.05; 55 (5): 531-538. ( ichushi )

  36. Chen Wei, Tanaka Hajime, Kobayashi Masaki, Fukuda Shohei, Nakayama Akinori, Meagher Margaret F., Yoshida Soichiro, Derweesh Ithaar H., Master Viraj A., Hirakawa Akihiro, Fujii Yasuhisa, Saito Kazutaka: 非転移性淡明細胞型腎細胞癌患者の予後を予測する術前C反応性蛋白値の人種差　INMARC研究(Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study) International Journal of Urology. 2025.04; 32 (4): 414-422. ( ichushi )

  37. Pioneering AI-guided fluorescence-like navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network. 2025.04; 19 (1): 188. ( PubMed , DOI )

  38. Chen W, Tanaka H, Kobayashi M, Fukuda S, Nakayama A, Meagher F M, Yoshida S, Derweesh I H, Master V A, Hirakawa A, Fujii Y, Saito K.: Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study. Int J Urol. 2025.04; 32 (4): 414-422. ( PubMed , DOI )

  39. Waseda Y, Chen W, Yokoyama M, Fukuda S, Tanaka H, Yoshida S, Ai M, Hirakawa A, Fushimi K, Fujii Y.: Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysis. Int J Urol. 2025.04; 32 (4): 409-413. ( PubMed , DOI )

  40. Chen Wei, Yoshida Soichiro, Miura Noriyoshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa: 転移性ホルモン感受性前立腺癌の次世代アンドロゲン受容体軸標的療法およびアンドロゲン除去療法へのドセタキセル追加療法の有効性　腫瘍体積に特化した解析(Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis) International Journal of Urology. 2025.04; 32 (4): 361-370. ( ichushi )

  41. Waseda Yuma, Chen Wei, Yokoyama Minato, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Hirakawa Akihiro, Fushimi Kiyohide, Fujii Yasuhisa: 良性副腎腫瘍に対する腹腔鏡下副腎摘除術の転帰に手術施行件数が及ぼす影響　日本全国データベース解析(Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysis) International Journal of Urology. 2025.04; 32 (4): 409-413. ( ichushi )

  42. Yasujima Rikuto, Tanaka Hajime, Tsuchiya Junichi, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa: 転移性尿路上皮癌患者におけるペムブロリズマブへの治療反応に対する18F-フルオロデオキシグルコースPET/CTの画像パラメータの影響(Impact of imaging parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma) International Journal of Urology. 2025.04; 32 (4): 453-455. ( ichushi )

  43. Rikuto Yasujima, Hajime Tanaka, Junichi Tsuchiya, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii: F-fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma. Int J Urol. 2025.04; 32 (4): 453-455. ( PubMed , DOI )

  44. Yuki Nakamura, Hajime Tanaka, Noboru Numao, Masaharu Inoue, Atsushi Yoshinaga, Naoko Kawamura, Kenji Tanabe, Keita Izumi, Takanobu Yamamoto, Sho Uehara, Yuya Maezawa, Takahiko Soma, Masahiro Toide, Ryoji Takazawa, Saori Araki, Soichiro Yoshida, Yasuhisa Fujii: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study). Clin Genitourin Cancer. 2025.04; 23 (2): 102301. ( PubMed , DOI )

  45. Patrizia Giannatempo, Jean-Pascal Machiels, Naoto Sassa, Jose Angel Arranz, Yasuhisa Fujii, Wen-Pin Su, Bhumsuk Keam, Stéphane Culine, Ying-Chun Shen, José Muñoz Langa, David Sarid, Maureen Aarts, Fabio Calabrò, Eli Rosenbaum, Blanca Homet Moreno, Abhishek Bavle, Jin Z Xu, Sun Young Rha: Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials. Clin Genitourin Cancer. 2025.04; 23 (2): 102273. ( PubMed , DOI )

  46. Wei Chen, Soichiro Yoshida, Yasuhisa Fujii: Is Docetaxel Essential for Darolutamide-Based Metastatic Hormone-Sensitive Prostate Cancer Therapy? Int J Urol. 2025.04; ( PubMed , DOI )

  47. Hiroshi Kikuchi, Takahiro Osawa, Yuto Matsushita, Takahiro Kojima, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kosuke Ueda, Hajime Tanaka, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Takuma Kato, Hiroaki Hara, Yoichi Ito, Hiroshi Kitamura, Hideaki Miyake, Nobuo Shinohara: Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study. Jpn J Clin Oncol. 2025.04; 55 (5): 531-538. ( PubMed , DOI )

  48. Yamamoto T, Yoshida S, Maezawa Y, Tamiya T, Toide M, Fukushima H, Uehara S, Araki S, Ito M, Kobayashi S, Yoshinaga A, Kawamura N, Takazawa R, Sakai Y, Ootsuka Y, Tsukamoto T, Nagahama K, Tanaka H, Kitabayashi R, Hanazawa R, Ishiguro M, Sato H, Koike R, Fujii Y: Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol BMJ Open. 2025.03; 15 (3): e094230. ( PubMed , DOI )

  49. Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi: Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2025.03; 116 (3): 572-580. ( PubMed , DOI )

  50. Matsumoto Shunya, Ishikawa Yudai, Fukushima Hiroshi, Yamamoto Kouhei, Tsujimoto Kazutaka, Kimura Koichiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor IJU Case Reports. 2025.03; 8 (2): 93-96. ( ichushi )

  51. Yamaya N, Kimura K, Ichikawa R, Kawanishi M, Kawasaki Y, Higuchi S, Fukui K, Tsuchiya J, Kobayashi M, Yoshida S, Fujii Y, Tateishi U: Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy. Japanese journal of radiology. 2025.03; 43 (3): 472-482. ( PubMed , DOI )

  52. Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Yasuhisa Fujii, Peter L Choyke, Hisataka Kobayashi: Antitumor host immunity enhanced by near-infrared photoimmunotherapy. Cancer Sci. 2025.03; 116 (3): 572-580.

  53. Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii: The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2025.03; 32 (3): 264-269.

  54. Nakamura Yuki, Yoshida Soichiro, Arita Yuki, Takeshita Ryo, Kimura Koichiro, Kobayashi Masaki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Jinzaki Masahiro, Fujii Yasuhisa: 膀胱画像報告データシステムに基づく高リスク筋層非浸潤性膀胱癌における2回目の経尿道的切除術の必要性(The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System) International Journal of Urology. 2025.03; 32 (3): 264-269. ( ichushi )

  55. Shunya Matsumoto, Yudai Ishikawa, Hiroshi Fukushima, Kouhei Yamamoto, Kazutaka Tsujimoto, Koichiro Kimura, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor. IJU case reports. 2025.03; 8 (2): 93-96. ( PubMed , DOI )

  56. Kohei Isemoto, Yuma Waseda, Motohiro Fujiwara, Koichiro Kimura, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Yuki Arita, Thomas C Kwee, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics (Basel). 2025.03; 15 (7): ( PubMed , DOI )

  57. Mori Kanami, Numakura Kazuyuki, Matsushita Yuto, Kojima Takahiro, Osawa Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Yamana Kazutoshi, Kandori Shuya, Kimura Takahiro, Nishiyama Naotaka, Bando Yukari, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kurahashi Toshifumi, Kitamura Hiroshi, Miyake Hideaki, Habuchi Tomonori: 転移性腎細胞癌患者におけるニボルマブ+イピリムマブ療法に対する一次耐性は二次治療の治療成績に影響を与える(Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma) Cancer Science. 2025.02; 116 (2): 444-452. ( ichushi )

  58. Kanami Mori, Kazuyuki Numakura, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazutoshi Yamana, Shuya Kandori, Takahiro Kimura, Naotaka Nishiyama, Yukari Bando, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Hiroshi Kitamura, Hideaki Miyake, Tomonori Habuchi: Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma. Cancer Sci. 2025.02; 116 (2): 444-452. ( PubMed , DOI )

  59. Mori M, Mori Y, Nakao Y, Mandai S, Fujiki T, Kikuchi H, Ando F, Susa K, Mori T, Waseda Y, Yoshida S, Fujii Y, Sohara E, Uchida S: Development of Adult Renal Tubular Organoids from Different Human Individuals in a Single Medium. JMA journal. 2025.01; 8 (1): 191-197. ( PubMed , DOI )

  60. Toshinari Horie, Motohiro Fujiwara, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. Int J Urol. 2025.01; 32 (1): 121-123. ( PubMed , DOI )

  61. Horie Toshinari, Fujiwara Motohiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 急性腎盂腎炎患者のhigh-dependency unit入室を予測するための非造影CTを用いたラジオミクス解析(Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis) International Journal of Urology. 2025.01; 32 (1): 121-123. ( ichushi )

  62. Wei Chen, Hajime Tanaka, Masaki Kobayashi, Shohei Fukuda, Akinori Nakayama, Margaret F Meagher, Rachel Greenwald, Benjamin Schmeusser, Edouard Nicase, Yuma Waseda, Soichiro Yoshida, Ithaar H Derweesh, Viraj A Master, Yasuhisa Fujii, Kazutaka Saito: Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry. World J Urol. 2025.01; 43 (1): 63. ( PubMed , DOI )

  63. Yuki Arita, Thomas C Kwee, Oguz Akin, Keisuke Shigeta, Ramesh Paudyal, Christian Roest, Ryo Ueda, Alfonso Lema-Dopico, Sunny Nalavenkata, Lisa Ruby, Noam Nissan, Hiromi Edo, Soichiro Yoshida, Amita Shukla-Dave, Lawrence H Schwartz: Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer. Insights Imaging. 2025.01; 16 (1): 7. ( PubMed , DOI )

  1. Kotaro Shimada, Motohiro Fujiwara, Daisuke Hirahara, Eichi Takaya, Soichiro Yoshida, Yasuhisa Fujii: Monitoring prostate cancer after low-dose-rate hemigland brachytherapy with delta-radiomics of diffusion-weighted magnetic resonance imaging. Int J Urol. 2024.12; 31 (12): 1443-1445. ( PubMed , DOI )

  2. Koichiro Kimura, Tatsuya Yamamoto, Junichi Tsuchiya, Soichiro Yoshida, Shuichi Yanai, Iichiro Onishi, Yasuhisa Fujii, Ukihide Tateishi: A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview. Abdom Radiol (NY). 2024.12; 49 (12): 4416-4436. ( PubMed , DOI )

  3. Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, Hajime Tanaka, Dattatraya Patil, Kit L Yuen, Luke Wang, Julian Cortes, Margaret F Meagher, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Massimo Lazzeri, Giovanni Lughezzani, Nicolò M Buffi, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2024.12; 22 (6): 102232. ( PubMed , DOI )

  4. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol. 2024.12; ( PubMed , DOI )

  5. Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii: The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2024.12; ( PubMed , DOI )

  6. Maezawa Yuya, Kobayashi Masaki, Murakami Masanori, Yamamura Ayumi, Naito Shotaro, Tanaka Hajime, Yoshida Soichiro, Yamada Tetsuya, Fujii Yasuhisa: 血液透析患者における褐色細胞腫切除後の遷延性低血糖(Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient) IJU Case Reports. 2024.11; 7 (6): 431-433. ( ichushi )

  7. Yanagi, T; Kikuchi, H; Takeuchi, K; Susa, K; Mori, T; Chiga, M; Yamamoto, K; Furukawa, A; Kanazawa, T; Kato, Y; Takahashi, N; Suzuki, T; Mori, Y; Carter, BC; Mori, M; Nakano, Y; Fujiki, T; Hara, Y; Suzuki, S; Ando, F; Mandai, S; Honda, S; Torii, S; Shimizu, S; Tanaka, H; Fujii, Y; Rai, T; Uchida, S; Sohara, E: ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease KIDNEY INTERNATIONAL. 2024.11; 106 (5): 887-906. ( PubMed , DOI )

  8. Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii: Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed , DOI )

  9. Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed , DOI )

  10. Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii: Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed , DOI )

  11. Yoshida Soichiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Fujii Yasuhisa: 内臓転移を認める同時性および異時性オリゴ転移性尿路上皮癌患者の転帰および予後因子(Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases) International Journal of Urology. 2024.11; 31 (11): 1234-1240. ( ichushi )

  12. Nakamura Yuki, Ishikawa Yudai, Kobayashi Masaki, Fujiwara Motohiro, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 膀胱マッピング生検における光線力学診断ガイド下生検の部位特異的診断効率(Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies) International Journal of Urology. 2024.11; 31 (11): 1263-1268. ( ichushi )

  13. Franklin Liu, Luke Wang, Margaret F Meagher, Jonathan Afari, Cesare Saitta, Sohail Dhanji, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi V Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan, Yusuke Aida, Yuya Maezawa, Shintaro Asai, Hajime Tanaka, Dattatraya Patil, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database. Urol Oncol. 2024.10; 42 (10): 333.e21-333.e31. ( PubMed , DOI )

  14. Julian A Cortes, Cesare Saitta, Kit L Yuen, Dattatraya Patil, Hajime Tanaka, Dhruv Puri, Jonathan A Afari, Mirha Mahmood, Joshua Matian, Mariam Mansour, Aaron Ahdoot, Luke Wang, Margaret F Meagher, Melis Guer, Mai Dabbas, Mimi V Nguyen, Clara Cerrato, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. Clin Genitourin Cancer. 2024.10; 22 (5): 102126. ( PubMed , DOI )

  15. Tanaka H, Yoshida S, Aoyama S, Ikeda S, Kunieda J, Ohashi K, Fukuda S, Waseda Y, Tanaka H, Fujii Y: A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU case reports. 2024.09; 7 (5): 395-398. ( PubMed , DOI )

  16. Tanabe Kenji, Kobayashi Shuichiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: ペムブロリズマブを投与されたプラチナ製剤抵抗性転移性尿路上皮癌患者における予後予測マーカーとしてのGustave Roussy免疫スコア　ゆしまstudy(Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study) International Journal of Clinical Oncology. 2024.09; 29 (9): 1302-1310. ( ichushi )

  17. Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii: Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed , DOI )

  18. Tanaka Hiroki, Yoshida Soichiro, Aoyama Satoru, Ikeda Sadakatsu, Kunieda Junko, Ohashi Kenichi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa: A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU Case Reports. 2024.09; 7 (5): 395-398. ( ichushi )

  19. Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii: Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma. Mod Pathol. 2024.08; 100590. ( PubMed , DOI )

  20. Srisopitsawat Pavarut, Obi Takashi, Lee Joong-Sun, Kobayashi Masaki, Tanaka Hajime, Ishioka Junichiro, Matsuoka Yoh: マルチモーダル医用画像を使用する腎腫瘍セグメンテーション法の、Transformerネットーワークによる改良(Enhancing Kidney Tumor Segmentation using Multi-Modal Medical Images with Transformer Networks) 日本医用画像工学会大会予稿集. 2024.08; 43回 110-111. ( ichushi )

  21. Fujiwara M, Shimada W, Yokoyama M, Koyanagi A, Shintaku H, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU case reports. 2024.07; 7 (4): 293-296. ( PubMed , DOI )

  22. Kobayashi M, Matsuoka Y, Uehara S, Tanaka H, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2024.07; 31 (7): 739-746. ( PubMed , DOI )

  23. Toide Masahiro, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Kimura Koichiro, Waseda Yuma, Yoshida Soichiro, Tateishi Ukihide, Fujii Yasuhisa: 小径腎腫瘤における脂肪成分の少ない腎血管筋脂肪腫の鑑別診断のためのCTとMRIを用いた段階的アルゴリズム　前向き検証研究(Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study) International Journal of Urology. 2024.07; 31 (7): 778-784. ( ichushi )

  24. Kobayashi Masaki, Matsuoka Yoh, Uehara Sho, Tanaka Hiroshi, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 臨床的限局性前立腺癌の予期せぬ前立腺外進展の予測にPI-RADSスコアと併用するMRI-超音波融合標的生検陽性コア数の有用性(Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer) International Journal of Urology. 2024.07; 31 (7): 739-746. ( ichushi )

  25. Fujiwara Motohiro, Shimada Wataru, Yokoyama Minato, Koyanagi Anri, Shintaku Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 転移性淡明細胞型腎細胞癌患者におけるニボルマブ再投与の持続的奏効(Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma) IJU Case Reports. 2024.07; 7 (4): 293-296. ( ichushi )

  26. Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii: Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed , DOI )

  27. Cesare Saitta, Jonathan A Afari, Dattatraya Patil, Hajime Tanaka, Kit L Yuen, Luke Wang, Julian Cortes, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Margaret F Meagher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry. Clin Genitourin Cancer. 2024.06; 22 (3): 102098. ( PubMed , DOI )

  28. Shintaro Asai, Masaki Kobayashi, Shohei Fukuda, Koichiro Kimura, Soichiro Yoshida, Yasuhisa Fujii: Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis. Int J Urol. 2024.06; 31 (6): 693-695. ( PubMed , DOI )

  29. Matsushita Yuto, Kojima Takahiro, Osawa Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kurahashi Toshifumi, Bando Yukari, Nishiyama Naotaka, Kimura Takahiro, Yamashita Shimpei, Kitamura Hiroshi, Miyake Hideaki, the Japanese Urological Oncology Group: 一次療法の癌免疫併用療法後にチロシンキナーゼ阻害薬による二次治療を受けた転移性腎細胞癌患者の予後転帰(Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy) International Journal of Urology. 2024.05; 31 (5): 526-533. ( ichushi )

  30. Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, : Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024.05; 31 (5): 526-533. ( PubMed , DOI )

  31. Cesare Saitta, Jonathan A Afari, Arman Walia, Dattatraya Patil, Hajime Tanaka, Kevin Hakimi, Luke Wang, Margaret F Meagher, Franklin Liu, Mimi V Nguyen, Dhruv Puri, Clara Cerrato, Ava Saidian, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry. Urol Oncol. 2024.04; 42 (4): 119.e1-119.e16. ( PubMed , DOI )

  32. Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii: Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1.

  33. Tateishi U, Kimura K, Tsuchiya J, Kano D, Watabe T, Nonomura N, Saito K, Yokoyama K, Yamagiwa K, Adachi T, Kojima Y, Yoshida S, Fujii Y: Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Japanese journal of clinical oncology. 2024.03; 54 (3): 282-291. ( PubMed , DOI )

  34. Ishikawa Yudai, Tanaka Hajime, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa: 経口5-アミノレブリン酸を使用した経尿道的膀胱腫瘍切除術中の低血圧の発生頻度および予測因子(Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid) International Journal of Urology. 2024.03; 31 (3): 238-244. ( ichushi )

  35. Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii: Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291.

  36. Fan Bo, Yokoyama Minato, Kobayashi Masaki, Nakamura Yuki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa: 根治的腎摘除術および腎部分切除術後の新たなベースライン推算糸球体濾過量から20%低下の術後2年以内の発生率、危険因子、意義(Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years) International Journal of Urology. 2024.02; 31 (2): 119-124. ( ichushi )

  37. Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii: Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507.

  38. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. 2024; 14 1527540. ( PubMed , DOI )

  39. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

  40. Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii: Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540.

  1. Matsuoka Y, Ueno Y, Uehara S, Tanaka H, Kobayashi M, Tanaka H, Yoshida S, Yokoyama M, Kumazawa I, Fujii Y: Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. International journal of urology : official journal of the Japanese Urological Association. 2023.12; 30 (12): 1103-1111. ( PubMed , DOI )

  2. Matsuoka Yoh, Ueno Yoshihiko, Uehara Sho, Tanaka Hiroshi, Kobayashi Masaki, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Kumazawa Itsuo, Fujii Yasuhisa: バイパラメトリックおよびマルチパラメトリックMRIを用いた深層学習による前立腺癌検出と輪郭描出　ダイナミック造影撮像の付加価値(Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging) International Journal of Urology. 2023.12; 30 (12): 1103-1111. ( ichushi )

  3. Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T: Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Scientific reports. 2023.11; 13 (1): 20629. ( PubMed , DOI )

  4. Ohba Kojiro, Monji Keisuke, Osawa Takahiro, Yamana Kazutoshi, Yasuda Yosuke, Tanaka Hajime, Nakagawa Yuki, Fukuyama Tamaki, Matsubara Nobuaki, Uemura Hirotsugu, Sakai Hideki, Eto Masatoshi: Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 977-984. ( ichushi )

  5. Ohba K, Monji K, Osawa T, Yamana K, Yasuda Y, Tanaka H, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H, Sakai H, Eto M: Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 977-984. ( PubMed , DOI )

  6. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y: Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; 22 (2): 193-200.e1. ( PubMed , DOI )

  7. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y: Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms. 2023.11; 16 (1): e12507. ( PubMed , DOI )

  8. Yudai Ishikawa, Hajime Tanaka, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii: Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. Int J Urol. 2023.11; 31 (3): 238-244. ( PubMed , DOI )

  9. Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa: Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1056-1058. ( ichushi )

  10. Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1014-1019. ( ichushi )

  11. Chen W, Yokoyama M, Waseda Y, Kobayashi M, Fan B, Fukuda S, Tanaka H, Yoshida S, Ai M, Fushimi K, Fujii Y: Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1014-1019. ( PubMed , DOI )

  12. Fan B, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y: Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. International journal of urology : official journal of the Japanese Urological Association. 2023.10; 31 (2): 119-124. ( PubMed , DOI )

  13. Yamaguchi Yoshitomo, Tanaka Hajime, Kimura Koichiro, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Hirakawa Akihiro, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa: Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma(タイトル和訳中) International Journal of Urology. 2023.10; 30 (10): 913-921. ( ichushi )

  14. Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa: The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer International Journal of Urology. 2023.07; 30 (7): 616-617. ( ichushi )

  15. Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa: A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy IJU Case Reports. 2023.07; 6 (4): 216-218. ( ichushi )

  16. Soma T, Yoshida S, Wakejima R, Taguchi T, Fukuda S, Tanaka H, Yokoyama M, Ohashi K, Okubo K, Fujii Y: A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU case reports. 2023.07; 6 (4): 216-218. ( PubMed , DOI )

  17. Yamaguchi Y, Tanaka H, Kimura K, Fukuda S, Fukushima H, Waseda Y, Yoshida S, Yokoyama M, Hirakawa A, Tateishi U, Campbell SC, Fujii Y: Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.06; ( PubMed , DOI )

  18. Yuki Mizuno, Soichiro Yoshida, Kentaro Okamoto, Yasuhisa Fujii: Utility of an endoscopic image processing system for framing laparoscopic images using surgeon's gaze point and voice commands during laparoscopic percutaneous extraperitoneal closure of inguinal hernia in children. Wideochir Inne Tech Maloinwazyjne. 2023.06; 18 (2): 372-377. ( PubMed , DOI )

  19. Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa: ロボット支援前立腺全摘除術後の鼠径ヘルニア予防のための腹膜閉鎖および鞘状突起離断法(Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy) International Journal of Urology. 2023.06; 30 (6): 532-538. ( ichushi )

  20. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y: Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology. 2023.04; ( PubMed , DOI )

  21. Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa: 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( ichushi )

  22. Uchida Y, Yokoyama M*, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y: Preservation of erectile and ejaculatory functions after tetramodal bladder-sparing therapy incorporating consolidative partial cystectomy against muscle invasive bladder cancer. Urology Research and Practice. 2023.04; ( DOI )

  23. Toshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, Sho Uehara, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma. Jpn J Clin Oncol. 2023.04; 53 (5): 436-442. ( PubMed , DOI )

  24. Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa: 根治的膀胱摘除術の動向およびロボット支援根治的膀胱摘除術に注目した外科的アプローチ間の手術成績の比較　日本の全国データベース研究(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study) International Journal of Urology. 2023.03; 30 (3): 258-263. ( ichushi )

  25. Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa: 筋層浸潤性膀胱癌患者に対する最大限の経尿道的切除術、導入化学放射線療法、地固め部分膀胱切除術からなる選択的4者併用膀胱温存療法後の腎機能転帰と根治的膀胱全摘術後の腎機能転帰との比較　2施設後ろ向き研究(Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( ichushi )

  26. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y: Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Japanese journal of clinical oncology. 2023.03; 53 (3): 263-269. ( PubMed , DOI )

  27. Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, Yuki Fukawa, Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii: Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed , DOI )

  28. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH: Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed , DOI )

  29. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy International Journal of Urology. 2023.02; 30 (2): 204-210. ( ichushi )

  1. Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh: Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed , DOI )

  2. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y: Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  3. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii: Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed , DOI )

  4. Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa: Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( ichushi )

  5. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y: Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed , DOI )

  6. Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa: コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( ichushi )

  7. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii YJinzaki M: Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology Eur Urol Oncol . 2022.08; ( DOI )

  8. Tanaka H, Fujii Y: Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.

  9. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii Y, Jinzaki M: Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. European urology oncology. 2022.08; 6 (1): 99-102. ( PubMed , DOI )

  10. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol . 2022.08; 18 (4): 410-418.

  11. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. 2022.08; 20 (4): 276-282.

  12. Tanaka H, Fujii Y: Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2022.08; 29 (8): 822-823. ( PubMed , DOI )

  13. Shumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, Sho Uehara, Yosuke Yasuda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii: Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol. 2022.08; 18 (4): 410-418. ( PubMed , DOI )

  14. Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer. 2022.08; 20 (4): e276-e282. ( PubMed , DOI )

  15. Tanaka Hajime, Fujii Yasuhisa: 「進行性腎細胞癌の一次治療としての複合癌免疫療法の包括的評価」に対するエディトリアルコメント(Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma) International Journal of Urology. 2022.08; 29 (8): 822-823. ( ichushi )

  16. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y: Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) . 2022.06; 47 (6): 2178-2186.

  17. Tanaka H, Fujii Y: Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. Int J Urol. 2022.06; 29 (6): 501-502.

  18. Tanaka H, Fujii Y: Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. International journal of urology : official journal of the Japanese Urological Association. 2022.06; 29 (6): 501-502. ( PubMed , DOI )

  19. Shunya Matsumoto, Yuki Arita, Soichiro Yoshida, Hiroshi Fukushima, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Fumiko Yagi, Minato Yokoyama, Yoh Matsuoka, Mototsugu Oya, Ukihide Tateishi, Masahiro Jinzaki, Yasuhisa Fujii: Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdom Radiol (NY). 2022.06; 47 (6): 2178-2186. ( PubMed , DOI )

  20. Tanaka Hajime, Fujii Yasuhisa: 「転移性腎細胞癌に対する外科的局所治療　文献レビュー」に対するエディトリアルコメント(Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review) International Journal of Urology. 2022.06; 29 (6): 501-502. ( ichushi )

  21. Nityam Rathi, Diego A Palacios, Emily Abramczyk, Hajime Tanaka, Yunlin Ye, Jianbo Li, Yosuke Yasuda, Robert Abouassaly, Mohamed Eltemamy, Alvin Wee, Christopher Weight, Steven C Campbell: Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022.04; 40 (4): 1011-1018. ( PubMed , DOI )

  22. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y: Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol . 2022.04; 40 (4): 161.

  23. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hiromi Edo, Ryohei Kufukihara, Keisuke Shigeta, Misa Nagasaka, Ryo Takeshita, Haruka Okamura, Ryo Ueda, Ryota Ishii, Shigeo Okuda, Yasuhisa Fujii: Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. Eur J Radiol. 2022.03; 148 110163. ( PubMed , DOI )

  24. Yoshida S, Matsushima H, Fujii Y: Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity World J Urol . 2022.03; 40 (3): 871-873.

  25. Yoshida S, Fujii Y: Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis Int J Urol . 2022.03; 29 (3): 196.

  26. Yusuke Uchida, Soichiro Yoshida, Yuki Arita, Hiroki Shimoda, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Masahiro Jinzaki, Yasuhisa Fujii: Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel). 2022.03; 12 (4): ( PubMed , DOI )

  27. Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis. Int J Urol. 2022.03; 29 (3): 196. ( PubMed , DOI )

  28. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y: Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel). 2022.03; 12 (4): 817.

  29. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH: Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.02; 131 (2): 219-226.

  30. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y: Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01; 14 (3): 567.

  31. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y: Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol . 2022.01; 32 (1): 671-679.

  32. Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii: Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers (Basel). 2022.01; 14 (3): 567. ( PubMed , DOI )

  33. Yuki Arita, Hirotaka Akita, Hirokazu Fujiwara, Masahiro Hashimoto, Keisuke Shigeta, Thomas C Kwee, Soichiro Yoshida, Takeo Kosaka, Shigeo Okuda, Mototsugu Oya, Masahiro Jinzaki: Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements. Eur J Radiol Open. 2022; 9 100403. ( PubMed , DOI )

  34. Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD : Kidney Cancer Screening and Epidemiology. Société Internationale d’Urologie Journal. 2022;

  35. Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I: Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022; 12 995991. ( PubMed , DOI )

  36. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y: Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  37. Cathrine Keiner, Margaret Meagher, Dattatraya Patil, Kazutaka Saito, Arman Walia, Franklin Liu, Raksha Dutt, Nathan Miller, Sohail Dhanji, Ava Saidian, Fang Wan, Yosuke Yasuda, Yasuhisa Fujii, Hajime Tanaka, Viraj Master, Ithaar Derweesh: Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Front Oncol. 2022; 12 995991. ( PubMed , DOI )

  38. Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I: Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

  1. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y: Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2021.12; ( PubMed , DOI )

  2. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018(和訳中) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( ichushi )

  3. Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa: 局所進行腎細胞癌における浸潤性腫瘍の正常腎実質との界面　臨床的意義と病理学的意味(Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications) International Journal of Urology. 2021.12; 28 (12): 1233-1239. ( ichushi )

  4. Yudai Ishikawa, Hiroshi Fukushima, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Yasuyuki Sakai, Yukihiro Otsuka, Ryoji Takazawa, Masataka Yano, Tetsuro Tsukamoto, Tetsuo Okuno, Akira Noro, Katsushi Nagahama, Shigeyoshi Kamata, Yasuhisa Fujii: Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel). 2021.12; 11 (12): 2277. ( PubMed , DOI )

  5. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y: Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

  6. Soichiro Yoshida, Yasuhisa Fujii: MRI-Targeted Biopsy in Prostate Cancer Screening. N Engl J Med. 2021.11; 385 (22): 2110. ( PubMed , DOI )

  7. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki: Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed , DOI )

  8. Maruyama Riko, Fukushima Hiroshi, Fukuda Shohei, Yasuda Yosuke, Uehara Sho, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 副腎腫瘍および腎腫瘍の清潔手術における予防的抗菌薬の不使用　連続患者1362例を対象としたリスクベース戦略の結果(Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients) International Journal of Urology. 2021.10; 28 (10): 1032-1038. ( ichushi )

  9. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese: First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed , DOI )

  10. Fujiwara Motohiro, Tanaka Hajime, Yuasa Takeshi, Komai Yoshinobu, Oguchi Tomohiko, Fujiwara Ryo, Numao Noboru, Yamamoto Shinya, Fujii Yasuhisa, Fukui Iwao, Yonese Junji: 播種性胚細胞癌に対するエトポシド、イホスファミド、シスプラチンによるファーストライン併用化学療法　現在の臨床現場における有効性と実施可能性(First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice) International Journal of Urology. 2021.09; 28 (9): 920-926. ( ichushi )

  11. Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa: Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018 INTERNATIONAL JOURNAL OF UROLOGY. 2021.09; 28 (12): 1268-1272. ( PubMed , DOI )

  12. Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, : Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed , DOI )

  13. Masaki Kobayashi, Junichiro Ishioka, Yoh Matsuoka, Yuichi Fukuda, Yusuke Kohno, Keizo Kawano, Shinji Morimoto, Rie Muta, Motohiro Fujiwara, Naoko Kawamura, Tetsuo Okuno, Soichiro Yoshida, Minato Yokoyama, Rumi Suda, Ryota Saiki, Kenji Suzuki, Itsuo Kumazawa, Yasuhisa Fujii: Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray. BMC Urol. 2021.08; 21 (1): 102. ( PubMed , DOI )

  14. Shimada W, Tanaka H, Fukawa Y, Kimura K, Yamamoto K, Fukuda S, Fukushima H, Yasuda Y, Uehara S, Yoshida S, Yokoyama M, Matsuoka Y, Tateishi U, Campbell SC, Fujii Y: Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. International journal of urology : official journal of the Japanese Urological Association. 2021.08; 28 (12): 1233-1239. ( PubMed , DOI )

  15. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed , DOI )

  16. Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa: Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy IJU Case Reports. 2021.07; 4 (4): 228-230. ( ichushi )

  17. Yoshida S, Fujii Y: Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2021.07; 28 (7): 756. ( PubMed , DOI )

  18. Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y: Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.07; ( PubMed , DOI )

  19. Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Tateishi Ukihide, Fujii Yasuhisa: Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer EUROPEAN RADIOLOGY. 2021.06; ( PubMed , DOI )

  20. Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y: Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. International journal of urology : official journal of the Japanese Urological Association. 2021.05; 28 (5): 502-513. ( PubMed , DOI )

  21. Yamazaki A, Ito T, Sugimoto M, Yoshida S, Honda K, Kawashima Y, Fujikawa T, Fujii Y, Tsutsumi T: Patient-specific virtual and mixed reality for immersive, experiential anatomy education and for surgical planning in temporal bone surgery. Auris, nasus, larynx. 2021.05; 48 (6): 1081-1091. ( PubMed , DOI )

  22. Arita Y, Yoshida S, Waseda Y, Takahara T, Ishii C, Ueda R, Kwee TC, Miyahira K, Ishii R, Okuda S, Jinzaki M, Fujii Y: Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. European journal of radiology. 2021.04; 137 109581. ( PubMed , DOI )

  23. Yoshida S, Fujii Y: Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports. 2021.03; 4 (2): 73-74. ( PubMed , DOI )

  24. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique(和訳中) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

  25. Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer(和訳中) IJU Case Reports. 2021.03; 4 (2): 73-74. ( ichushi )

  26. Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y: Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.03; 54 (2): 401-408. ( PubMed , DOI )

  27. Sweet DE, Ward RD, Wang Y, Tanaka H, Campbell SC, Remer EM: Infiltrative Renal Malignancies: Imaging Features, Prognostic Implications, and Mimics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021.03; 41 (2): 487-508. ( PubMed , DOI )

  28. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International Journal of Urology. 2021.02; 28 (2): 241-242. ( ichushi )

  29. Fukuda S, Saito K, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kageyama Y, Fujii Y: Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer. 2021.02; 9 (2): ( PubMed , DOI )

  30. Tanaka H, Fujii Y: Editorial Comment. The Journal of urology. 2021.02; 205 (5): 101097JU000000000000154902-1320. ( PubMed , DOI )

  31. Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa: 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( ichushi )

  32. Yoshida S, Matsushima H, Fujii Y: Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World journal of urology. 2021.01; ( PubMed , DOI )

  33. Fukushima Hiroshi, Yoshida Soichiro, Kijima Toshiki, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa: Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (2): ( PubMed , DOI )

  34. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems(和訳中) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

  35. Tanaka Hajime, Fujii Yasuhisa: Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 16. ( PubMed , DOI )

  36. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa: Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed , DOI )

  37. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 127-129. ( PubMed , DOI )

  38. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y: Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed , DOI )

  39. Tanaka Hajime, Fujii Yasuhisa: 「膀胱癌に対するリンパ節郭清　現行の基準と最新のエビデンス」に対するエディトリアルコメント(Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence) International Journal of Urology. 2021.01; 28 (1): 16. ( ichushi )

  40. Saito Kazutaka, Matsuoka Yoh, Toda Kazuma, Yoshida Soichiro, Yokoyama Minato, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer BRACHYTHERAPY. 2021; 20 (4): 842-848. ( PubMed , DOI )

  41. Waseda Y, Yoshida S, Arita Y, Takahara T, Sakamoto T, Saito K, Fujii Y: Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy. Urologia internationalis. 2021; 105 (5-6): 507-513. ( PubMed , DOI )

  1. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y: Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. International journal of urology : official journal of the Japanese Urological Association. 2020.12; ( PubMed , DOI )

  2. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. : Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol.. 2020.12;

  3. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  4. Tanaka Hajime: Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management(和訳中) International Journal of Urology. 2020.12; 27 (12): 1071. ( ichushi )

  5. Tanaka Hajime: Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management INTERNATIONAL JOURNAL OF UROLOGY. 2020.12; 27 (12): 1071. ( PubMed , DOI )

  6. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y: Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International journal of urology : official journal of the Japanese Urological Association. 2020.11; ( PubMed , DOI )

  7. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer medicine. 2020.11; 9 (22): 8355-8363. ( PubMed , DOI )

  8. Palacios Diego Aguilar, Campbell Rebecca, Wang Yanbo, Tanaka Hajime, Ding Xiaobo, Ye Yun-Lin, Remer Erick M., Rizk Alain, Ward Ryan, Haywood Samuel, Campbell Steven C.: Infiltrative Renal Masses: Clinical Challenges UROLOGY. 2020.11; 145 3-8. ( PubMed , DOI )

  9. 田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久: 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS13-1. ( ichushi )

  10. 福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久: 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS14-1. ( ichushi )

  11. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

  12. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anti-cancer drugs. 2020.09; 31 (8): 866-871. ( PubMed , DOI )

  13. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer immunology, immunotherapy : CII. 2020.09; ( PubMed , DOI )

  14. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  15. Tanaka Hajime: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision(和訳中) International Journal of Urology. 2020.09; 27 (9): 710. ( ichushi )

  16. Tanaka Hajime: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 710. ( PubMed , DOI )

  17. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yoshimura Ryoichi, Fujii Yasuhisa: Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer(和訳中) International Journal of Urology. 2020.07; 27 (7): 634-635. ( ichushi )

  18. Kaneko Kasumi, Yoshida Soichiro, Yamamoto Kouhei, Arita Yuki, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging(和訳中) International Journal of Urology. 2020.07; 27 (7): 599-604. ( ichushi )

  19. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clinical genitourinary cancer. 2020.07; ( PubMed , DOI )

  20. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa: Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy (vol 27, pg 471, 2020) INTERNATIONAL JOURNAL OF UROLOGY. 2020.07; 27 (7): 636. ( DOI )

  21. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

  22. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 599-604. ( PubMed , DOI )

  23. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y: Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 634-635. ( PubMed , DOI )

  24. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. International journal of urology : official journal of the Japanese Urological Association. 2020.06; ( PubMed , DOI )

  25. Yoshida Soichiro, Taniguchi Naoji, Moriyama Shingo, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: MRI撮影-超音波検査融合画像による前立腺生検の患者説明におけるバーチャルリアリティの応用(Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy) International Journal of Urology. 2020.05; 27 (5): 471-472. ( ichushi )

  26. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Lower urinary tract symptoms. 2020.04; ( PubMed , DOI )

  27. Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

  28. Tanaka Hajime, Fujii Yasuhisa: Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 257. ( PubMed , DOI )

  29. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.03; 27 (3): 236-243. ( PubMed , DOI )

  30. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y: Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed , DOI )

  31. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y: Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  32. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y: Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed , DOI )

  33. Tanaka Hajime, Fujii Yasuhisa: 「膀胱癌に対する根治的腹腔鏡下膀胱全摘術後の腫瘍学的成績と再発パターン　日本の多施設コホート」に対するDr.TanakaとDr.Fujiiによるエディトリアルコメント(Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort) International Journal of Urology. 2020.03; 27 (3): 257. ( ichushi )

  34. Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC: Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. The Journal of urology. 2020.02; 101097JU0000000000000797. ( PubMed , DOI )

  35. Ye Yunlin, Tanaka Hajime, Wang Yanbo, Campbell Rebecca A., Aguilar Palacios Diego, DeWitt-Foy Molly E., Mahmood Furman A., Eltemamy Mohamed, Remer Erick M., Li Jianbo, Campbell Steven C.: Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans BJU INTERNATIONAL. 2020.02; 125 (5): 686-694. ( PubMed , DOI )

  36. Tanaka H, Kijima T, Fujii Y: Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

  37. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. Clinical genitourinary cancer. 2020.02; ( PubMed , DOI )

  38. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; ( PubMed , DOI )

  39. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. : Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol. 2020; 27: 634-635. doi: 10.1111/iju.14249.. 2020;

  40. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. : Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

  41. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. : Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  42. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  43. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

  44. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  45. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y: Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  46. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y: Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  47. Ye Y*, Tanaka H*, Wang Y, Campbell RA, Aguilar Palacios D, Dewitt-Foy ME, Mahmood FA, Eltemamy M, Remer EM, Li J, Campbell SC: Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans BJU International. 2020; 125: 686-694. *Equal contribution. 2020;

  48. Tanaka H: Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association -Summary of the Revision Int J Urol. 2020. doi: 10.1111/iju.14314. 2020;

  49. Tanaka H: Editorial Comment to Retroperitoneal tumors: review of diagnosis and management Int J Urol. 2020; 27: 1071. 2020;

  50. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  51. Tanaka H, Fujii Y: Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

  52. Tanaka H, Fujii Y: Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

  53. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y: Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  54. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y: Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  1. Toshiki Kijima, Hajime Tanaka, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

  2. SoichiroYoshida, TaroTakahara, Chikako Ishii, Yuki Arita, Yuma Waseda, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  3. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed , DOI )

  4. Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y: METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019.12; ( PubMed , DOI )

  5. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y: Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed , DOI )

  6. Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell: Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed , DOI )

  7. Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell: The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed , DOI )

  8. Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell: Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed , DOI )

  9. Kijima Toshiki, Tanaka Hajime, Koga Fumitaka, Masuda Hitoshi, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int. 2019.08; 124 (2): 242-250. ( PubMed , DOI )

  10. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int J Urol. 2019.08; 26 (8): 820-826. ( PubMed , DOI )

  11. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

  12. Yoshida Soichiro, Fujii Yasuhisa: Editorial Comment to Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management. Int J Urol. 2019.07; ( PubMed , DOI )

  13. Yajima Shugo, Yoshida Soichiro, Takahara Taro, Arita Yuki, Tanaka Hiroshi, Waseda Yuma, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol. 2019.07; 29 (7): 3881-3888. ( PubMed , DOI )

  14. Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell: Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed , DOI )

  15. Yoshida S, Takahara T, Arita Y, Ishii C, Uchida Y, Nakagawa K, Toda K, Sakamoto T, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y: Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. International journal of radiation oncology, biology, physics. 2019.06; ( PubMed , DOI )

  16. Yoshida Soichiro, Maeda Takeshi, Yokoyama Minato, Toide Masahiro, Saito Kazutaka, Fujii Yasuhisa: Application of eye tracking as a user interface for urological surgery. Int J Urol. 2019.06; 26 (6): 680-681. ( PubMed , DOI )

  17. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa: Mixed reality computed tomography-based surgical planning for partial nephrectomy using a head-mounted holographic computer. Int J Urol. 2019.06; 26 (6): 681-682. ( PubMed , DOI )

  18. Arita Yuki, Takahara Taro, Yoshida Soichiro, Kwee Thomas C, Yajima Shugo, Ishii Chikako, Ishii Ryota, Okuda Shigeo, Jinzaki Masahiro, Fujii Yasuhisa: Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.05; ( PubMed , DOI )

  19. Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell: Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed , DOI )

  20. Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell: Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed , DOI )

  21. Kijima Toshiki, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2019.03; 37 (7):

  22. Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell: Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed , DOI )

  23. Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa: Incidence and predictive factors of hypoglycemia after pheochromocytoma resection(和訳中) International Journal of Urology. 2019.02; 26 (2): 273-277. ( ichushi )

  24. Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

  25. Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi: A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.01; ( PubMed , DOI )

  1. Yoshida Soichiro, Fujii Yasuhisa: High cell proliferation as a predictive factor for favorable response to chemoradiotherapy against bladder cancer CANCER SCIENCE. 2018.12; 109 1220.

  2. Saori Araki, Toshiki Kijima, Yuma Waseda, Yoshinobu Komai, Yasukazu Nakanishi, Sho Uehara, Yosuke Yasuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yujiro Nakano, Takanobu Yoshimoto, Tokujiro Uchida, Yasuhisa Fujii: Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. Int. J. Urol.. 2018.11; ( PubMed , DOI )

  3. Ryan D Ward, Hajime Tanaka, Steven C Campbell, Erick M Remer: 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics. 2018.11; 38 (7): 2021-2033. ( PubMed , DOI )

  4. Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa: 造影CTとT2強調MRIによる脂肪に乏しい血管筋脂肪腫の診断を目的とした畳み込みニューラルネットワークアルゴリズムを用いたコンピュータ補助診断の可能性(Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging) International Journal of Urology. 2018.11; 25 (11): 978-979. ( ichushi )

  5. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  6. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  7. Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y: Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed , DOI )

  8. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  9. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  10. Yoshida Soichiro, Takahara Taro, Ishii Chikako, Nakagawa Keiko, Toda Kazuma, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa: Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 358.

  11. Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Fujii Yasuhisa: MRI/ultrasound elastic fusion prostate biopsy : application to lesion - specific treatment of local therapy INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 167.

  12. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  13. Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y: Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology . 2018.09; ( PubMed , DOI )

  14. Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y: Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Clinical genitourinary cancer. 2018.08; ( PubMed , DOI )

  15. Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed , DOI )

  16. Alice Crane, Chalairat Suk-Ouichai, Jack A Campbell, Elvis R Caraballo, Diego Aguilar Palacios, Hajime Tanaka, Steven C Campbell: Imprudent Utilization of Partial Nephrectomy. Urology. 2018.07; 117 22-26. ( PubMed , DOI )

  17. Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, J J H Zhang, Elvis Caraballo, Erick Remer, Jianbo Li, Sudhir Isharwal, Steven C Campbell: Tumor Contact Surface Area As a Predictor of Functional Outcomes After Standard Partial Nephrectomy: Utility and Limitations. Urology. 2018.06; 116 106-113. ( PubMed , DOI )

  18. Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma(和訳中) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

  19. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.06; 25 (6): 554-560. ( PubMed , DOI )

  20. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed , DOI )

  21. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii: Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed , DOI )

  22. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( ichushi )

  23. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa: Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes(和訳中) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( ichushi )

  24. Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2018.02; 36 (6):

  25. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii: Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed , DOI )

  1. Yoshida Soichiro, Fukuyo Tsuneo, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 単孔式腹腔鏡下手術における手-目協調の改善のためのリアルタイム三次元画像の角度調整(Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery) International Journal of Urology. 2017.08; 24 (8): 639-640. ( ichushi )

  2. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed , DOI )

  3. Soichiro Yoshida, Tsuneo Fukuyo, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery. Int. J. Urol.. 2017.08; 24 (8): 639-640. ( PubMed , DOI )

  4. Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii: Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. J Magn Reson Imaging. 2017.08; 46 (2): 490-496. ( PubMed , DOI )

  5. Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori: 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム　開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( ichushi )

  6. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed , DOI )

  7. Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara: Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed , DOI )

  8. Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori: 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( ichushi )

  9. Soichiro Yoshida, Taro Takahara, Thomas C Kwee, Yuma Waseda, Shuichiro Kobayashi, Yasuhisa Fujii: DWI as an Imaging Biomarker for Bladder Cancer. AJR Am J Roentgenol. 2017.06; 208 (6): 1218-1228. ( PubMed , DOI )

  10. Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara: Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed , DOI )

  11. Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa: 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( ichushi )

  12. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed , DOI )

  1. Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: A novel interactive educational system in the operating room--the IE system. BMC Med Educ. 2016.02; 16 44. ( PubMed , DOI )

  2. Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara: Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed , DOI )

  1. Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese: Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed , DOI )

  2. Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese: Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed , DOI )

  3. Kenji Tanabe, Soichiro Yoshida, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara: High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clinical genitourinary cancer. 2015.08; 13 (4): e243-e251. ( PubMed , DOI )

  4. Soichiro Yoshida, Asami Sasaki, Chikage Sato, Mutsuko Yamazaki, Junya Takayasu, Naofumi Tanaka, Norie Okabayashi, Hiromi Hirano, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: A Novel Approach to Surgical Instructions for Scrub Nurses by Using See-Through-Type Head-Mounted Display. Comput Inform Nurs. 2015.08; 33 (8): 335-338. ( PubMed , DOI )

  5. Soichiro Yoshida, Kazunori Kihara, Tsuneo Fukuyo, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii: Novel three-dimensional image system for transurethral surgery. Int. J. Urol.. 2015.07; 22 (7): 714-715. ( PubMed , DOI )

  6. Soichiro Yoshida, Naotaka Fukui, Kazutaka Saito, Yasuhisa Fujii, Yukio Kageyama, Kazunori Kihara: Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. Int. J. Urol.. 2015.05; 22 (5): 520-521. ( PubMed , DOI )

  7. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urologia internationalis. 2015.04; ( PubMed , DOI )

  8. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii: Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  9. Inoue Masaharu, Kihara Kazunori, Yoshida Soichiro, Ito Masaya, Takeshita Hideki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. J Ultrasound Med. 2015.01; 34 (1): 29-35. ( PubMed , DOI )

  10. Manabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, Kazunori Kihara: Heat shock protein 90 targeting therapy: state of the art and future perspective. EXCLI journal. 2015; 14 48-58. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. Int J Urol. 2014.12; 21 (12): 1190-1200. ( PubMed , DOI )

  2. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa: A head-mounted display-based personal integrated-image monitoring system for transurethral resection of the prostate. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 644-649. ( PubMed , DOI )

  3. Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka: A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed , DOI )

  4. Ishioka Junichiro, Kihara Kazunori, Higuchi Saori, Nakayama Takayuki, Takeshita Hideki, Yoshida Soichiro, Nakanishi Yasukazu, Kijima Toshiki, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014.11; 40 (6): 842-845. ( PubMed )

  5. Uchida Yusuke, Yoshida Soichiro, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K: Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. The British journal of radiology. 2014.10; 87 (1042): 20130791. ( PubMed , DOI )

  6. Junichiro Ishioka, Hitoshi Masuda, Toshiki Kijima, Manabu Tatokoro, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Yasuyuki Sakai, Chizuru Arisawa, Tetsuo Okuno, Katsuhi Nagahama, Shigeyoshi Kamata, Junji Yonese, Yukio Kageyama, Akira Noro, Shinji Morimoto, Toshihiko Tsujii, Satoshi Kitahara, Shuichi Gotoh, Kazunori Kihara: Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer Res.. 2014.10; 34 (10): 5683-5688. ( PubMed )

  7. Inoue Masaharu, Koga Fumitaka, Yoshida Soichiro, Tamura Tomoki, Fujii Yasuhisa, Ito Eisaku, Kihara Kazunori: Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. Int J Radiat Oncol Biol Phys. 2014.10; 90 (2): 303-311. ( PubMed , DOI )

  8. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa: Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education. Wideochir Inne Tech Malo Inwazyjne. 2014.09; 9 (3): 449-452. ( PubMed , DOI )

  9. Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: Clinical application of a modern high-definition head-mounted display in sonography. J Ultrasound Med. 2014.08; 33 (8): 1499-1504. ( PubMed , DOI )

  10. Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori: Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Jpn J Clin Oncol. 2014.08; 44 (8): 756-761. ( PubMed , DOI )

  11. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori: Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU Int. 2014.08; ( PubMed , DOI )

  12. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa: Head-Mounted Display for a Personal Integrated Image Monitoring System: Ureteral Stent Placement. Urol Int. 2014.08; ( PubMed , DOI )

  13. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Tanaka Hiroshi, Satoh Shiro, Fujii Yasuhisa, Kihara Kazunori: Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World J Radiol. 2014.06; 6 (6): 344-354. ( PubMed , DOI )

  14. Takeshita Hideki, Kawakami Satoru, Numao Noboru, Sakura Mizuaki, Tatokoro Manabu, Yamamoto Shinya, Kijima Toshiki, Komai Yoshinobu, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Fukui Iwao, Kihara Kazunori: Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU Int. 2014.04; ( PubMed , DOI )

  15. Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori: Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014.03; 46 (3): 555-561. ( PubMed , DOI )

  16. Ishioka Junichiro, Saito Kazutaka, Kijima Toshiki, Nakanishi Yasukazu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Sakura Mizuaki, Yonese Junji, Morimoto Shinji, Noro Akira, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Higashi Yotsuo, Kihara Kazunori: Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2014.02; ( PubMed , DOI )

  17. Mollapour Mehdi, Bourboulia Dimitra, Beebe Kristin, Woodford Mark R, Polier Sigrun, Hoang Anthony, Chelluri Raju, Li Yu, Guo Ailan, Lee Min-Jung, Fotooh-Abadi Elham, Khan Sahar, Prince Thomas, Miyajima Naoto, Yoshida Soichiro, Tsutsumi Shinji, Xu Wanping, Panaretou Barry, Stetler-Stevenson William G, Bratslavsky Gennady, Trepel Jane B, Prodromou Chrisostomos, Neckers Len: Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Molecular Cell. 2014.01; 53 (2): 317-329. ( PubMed , DOI )

  18. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori: Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014.01; 65 (1): 186-192. ( PubMed , DOI )

  19. Kobayashi Shuichiro, Koga Fumitaka, Kajino Kohei, Yoshita Soichiro, Ishii Chikako, Tanaka Hiroshi, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamada Tetsuo, Kihara Kazunori: Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging. 2014.01; 39 (1): 172-178. ( PubMed , DOI )

  20. Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori: Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urol Int. 2014; 93 (2): 170-175. ( PubMed , DOI )

  1. Miyajima Naoto, Tsutsumi Shinji, Sourbier Carole, Beebe Kristin, Mollapour Mehdi, Rivas Candy, Yoshida Soichiro, Trepel Jane B, Huang Ying, Tatokoro Manabu, Shinohara Nobuo, Nonomura Katsuya, Neckers Len: The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Research. 2013.12; 73 (23): 7022-7033. ( PubMed , DOI )

  2. Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013.09; 190 (3): 867-873. ( PubMed , DOI )

  3. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 2013.08; 190 (2): 502-508. ( PubMed , DOI )

  4. Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. 2013.08; 23 (8): 2206-2214. ( PubMed , DOI )

  5. Hiroshi Fukushima, Hitoshi Masuda, Minato Yokoyama, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara: Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn. J. Clin. Oncol.. 2013.07; 43 (7): 740-746. ( PubMed , DOI )

  6. Manabu Tatokoro, Kazunori Kihara, Hitoshi Masuda, Masaya Ito, Soichiro Yoshida, Toshiki Kijima, Minato Yokoyama, Kazutaka Saito, Fumitaka Koga, Satoru Kawakami, Yasuhisa Fujii: Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol. 2013.07; 13 35. ( PubMed , DOI )

  7. Yoshida Soichiro, Tsutsumi Shinji, Muhlebach Guillaume, Sourbier Carole, Lee Min-Jung, Lee Sunmin, Vartholomaiou Evangelia, Tatokoro Manabu, Beebe Kristin, Miyajima Naoto, Mohney Robert P, Chen Yang, Hasumi Hisashi, Xu Wanping, Fukushima Hiroshi, Nakamura Ken, Koga Fumitaka, Kihara Kazunori, Trepel Jane, Picard Didier, Neckers Leonard: Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 2013.04; 110 (17): E1604-E1612. ( PubMed , DOI )

  8. Tanaka Hajime, Yuasa Takeshi, Fujii Yasuhisa, Sakura Mizuaki, Urakami Shinji, Yamamoto Shinya, Masuda Hitoshi, Fukui Iwao, Yonese Junji: First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed , DOI )

  9. Kijima Toshiki, Koga Fumitaka, Fujii Yasuhisa, Yoshida Soichiro, Tatokoro Manabu, Kihara Kazunori: Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 2013; 8 (5): e64615. ( PubMed , DOI )

  1. Iwai Aki, Bourboulia Dimitra, Mollapour Mehdi, Jensen-Taubman Sandra, Lee Sunmin, Donnelly Alison C, Yoshida Soichiro, Miyajima Naoto, Tsutsumi Shinji, Smith Armine K, Sun David, Wu Xiaolin, Blagg Brian S, Trepel Jane B, Stetler-Stevenson William G, Neckers Len: Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012.10; 11 (19): 3649-3655. ( PubMed , DOI )

  2. Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori: Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed , DOI )

  3. Yuma Waseda, Hajime Tanaka, Kazuaki Nakagomi, Shuichi Goto, Akio Ido: A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile. Jpn. J. Clin. Oncol.. 2012.08; 42 (8): 767-769. ( PubMed , DOI )

  4. Tatokoro Manabu, Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Fujii Yasuhisa, Neckers Len, Kihara Kazunori: Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer. 2012.08; 131 (4): 987-996. ( PubMed , DOI )

  5. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed , DOI )

  6. Numao Noboru, Kawakami Satoru, Sakura Mizuaki, Yoshida Soichiro, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori: Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int. 2012.03; 109 (5): 665-671. ( PubMed , DOI )

  7. Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru: Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 2012.03; 109 (6): 860-866. ( PubMed , DOI )

  8. Tsutsumi Shinji, Mollapour Mehdi, Prodromou Chrisostomos, Lee Chung-Tien, Panaretou Barry, Yoshida Soichiro, Mayer Matthias P, Neckers Leonard M: Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proceedings of the National Academy of Sciences of the United States of America. 2012.02; 109 (8): 2937-2942. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori: Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle. 2011.12; 10 (24): 4291-4299. ( PubMed , DOI )

  2. Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori: Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed , DOI )

  3. Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. 2011.10; 21 (10): 2178-2186. ( PubMed , DOI )

  4. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori: Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol. 2011.01; 196 (1): 110-116. ( PubMed , DOI )

  5. Koga Fumitaka, Yoshida Soichiro, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori: ErbB2 and NFkappaB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One. 2011; 6 (11): e27616. ( PubMed , DOI )

  1. Yoshida Soichiro, Koga Fumitaka, Kawakami Satoru, Ishii Chikako, Tanaka Hiroshi, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori: Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010.02; 75 (2): 387-391. ( PubMed , DOI )

  1. Fukushima Hiroshi, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Yoshida Soichiro, Ratovitski Edward, Trink Barry, Kihara Kazunori: Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Res. 2009.12; 69 (24): 9263-9270. ( PubMed , DOI )

  2. Koga Fumitaka, Kihara Kazunori, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Masuda Hitoshi, Kageyama Yukio, Kawakami Satoru: Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009.07; 104 (2): 189-194. ( PubMed , DOI )

  3. Yokoyama M, Fujii Y, Yoshida S, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K: Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed , DOI )

  1. Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K: Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed , DOI )

  2. Yoshida S, Fujii Y, Yokoyama M, Ishii C, Saito K, Koga F, Masuda H, Kobayashi T, Kawakami S, Kihara K: Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed , DOI )

  3. Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K: C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008.04; 101 (8): 978-981. ( PubMed , DOI )

  4. Masuda Hitoshi, Kihara Kazunori, Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Chancellor Michael B, de Groat William C, Yoshimura Naoki: Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU international. 2008.03; 101 (6): 775-780. ( PubMed , DOI )

  5. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori: Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2008.02; 15 (2): 140-143. ( PubMed , DOI )

  1. Yoshida Soichiro, Hayashi Tetsuo, Morozumi Makoto, Osada Hisato, Honda Norinari, Yamada Takumi: Three-dimensional assessment of urinary stone on non-contrast helical computed tomography as the predictor of stonestreet formation after extracorporeal shock wave lithotripsy for stones smaller than 20 mm. International journal of urology : official journal of the Japanese Urological Association. 2007.07; 14 (7): 665-667. ( PubMed , DOI )

  2. Yoshida S, Masuda H, Yokoyama M, Kobayashi T, Kawakami S, Kihara K: Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. Int J Urol. 2007.05; 14 (5): 384-387. ( PubMed , DOI )

  3. Yoshida Soichiro, Hayashi Tetsuo, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi: Discrimination between ureteral stent and stone by non-contrast helical computed tomography in the clinical setting. International journal of urology : official journal of the Japanese Urological Association. 2007.02; 14 (2): 171-173. ( PubMed , DOI )

  1. Yoshida Soichiro, Hayashi Tetsuo, Ikeda Jun, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi: Role of volume and attenuation value histogram of urinary stone on noncontrast helical computed tomography as predictor of fragility by extracorporeal shock wave lithotripsy. Urology. 2006.07; 68 (1): 33-37. ( PubMed , DOI )

  2. Hayashi Tetsuo, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Yamada Takumi: Asthenospermia in hay fever patients improved by stopping treatment with histamine H1 receptor antagonists. Int J Urol. 2006.07; 13 (7): 1028-1030. ( PubMed , DOI )

  3. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo: C-choline positron emission tomography in bladder cancer: report of four cases. International journal of urology : official journal of the Japanese Urological Association. 2006.06; 13 (6): 829-831. ( PubMed , DOI )

  4. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi: HtrA2 is up-regulated in the rat testis after experimental cryptorchidism. International journal of urology : official journal of the Japanese Urological Association. 2006.02; 13 (2): 157-164. ( PubMed , DOI )

  5. Yoshida Soichiro, Hayashi Tetsuo, Ishii Nobuyuki, Yoshinaga Atsushi, Ohno Rena, Terao Toshiya, Watanabe Toru, Yamada Takumi, Osada Hisato: Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis. International urology and nephrology. 2006; 38 (3-4): 413-415. ( PubMed , DOI )

  1. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi: Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin. Scandinavian journal of urology and nephrology. 2005; 39 (5): 431-432. ( PubMed , DOI )

  2. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo: 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urologia internationalis. 2005; 74 (3): 214-220. ( PubMed , DOI )

  1. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Ozawa Takachika: Cystic hamartoma of the renal pelvis. International journal of urology : official journal of the Japanese Urological Association. 2004.08; 11 (8): 653-655. ( PubMed , DOI )

  2. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Kobayashi Satoshi: Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. International journal of urology : official journal of the Japanese Urological Association. 2004.03; 11 (3): 175-177. ( PubMed )

  3. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi: Abscess formation in the prevesical space and bilateral thigh muscles secondary to osteomyelitis of the pubis--basis of the anatomy between the prevesical space and femoral sheath. Scandinavian journal of urology and nephrology. 2004; 38 (5): 440-441. ( PubMed , DOI )

  1. Matsuoka Y, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Numao N, Saito K, Fujii Y, Kihara K: Gassless single-port RoboSurgeon radical prostatectomy using an endoscopic manipulator robot 2016.07; 8 (1): 31-35.

  1. Moriyama Shingo, Yoshida Soichiro, Takeshita Hideki, Kurata Morito, Okada Yohei, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Fuji Yasuhisa, Kawakami Satoru, Kihara Kazunori: Case of inflammatory lesion in urinary bladder showing high signal intensity on diffusion-weighted MRI: correlation with histopathological finding. Nihon Hinyokika Gakkai Zasshi. 2013.05; 104 (3): 545-548. ( PubMed )

  1. Tanaka Hajime, Masuda Hitoshi, Komai Yoshinobu, Yokoyama Minato, Iwai Aki, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Fujii Yasuhisa, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori: Primary adenocarcinoma of the female urethra treated by multimodal therapy Hinyokika Kiyo. 2009.01; 55 (1): 43-46. ( PubMed )

  1. Nakayama Takayuki, Yoshida Soichiro, Fujii Yasuhisa, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori: Use of diffusion-weighted MRI in monitoring response of lymph node metastatic bladder cancer treated with chemotherary 2008.11; 99 (7): 737-741. ( PubMed )

  1. Yoshinaga Atsushi, Yoshida Soichiro, Nakagomi Kazuaki, Goto Syuichi: A case of vesicourethral foreign body for catheterization by scallion: historical discussion about urethral catheter 2007.07; 98 (5): 710-712. ( PubMed )

  2. Yoshinaga Atsushi, Morozumi Makoto, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Kamata Shigeyoshi, Hayashi Tetsuo, Yamada Takumi: A case of hypospadias with a dicentric Y chromosome 2007.01; 98 (1): 30-33. ( PubMed )

  1. Komai Yoshinobu, Kawakami Satoru, Yoshida Soichiro, Sakai Yasuyuki, Kobayashi Tsuyoshi, Kageyama Yukio, Kihara Kazunori: A case of cystic ganglioneuroma of adrenal gland presenting as a huge retroperitoneal mass 2006.07; 52 (7): 549-551. ( PubMed )

  2. Yoshinaga Atsushi, Hayashi Tetsuo, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Watanabe Toru, Yamada Takumi: Comparison and outcome of prevalence of concurrent diseases in patients with urological malignant diseases 2006.07; 52 (7): 537-541. ( PubMed )

  3. Primary leiomyosarcoma of the spermatic cord with an unusually indolent clinical course 2006.02; 52 (2): 159-161. ( PubMed )

  4. Yoshida Soichiro, Watanabe Toru, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Hayashi Tetsuo, Yamada Takumi: Inflammatory myofibroblastic tumor of the renal pelvis 2006.01; 52 (1): 31-33. ( PubMed )

  1. Yoshida Soichiro, Hayashi Tetsuo, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Watanabe Toru, Yamada Takumi: [Metastatic tumor of spermatic cord with elevation of serum human chorionic gonadotropin beta-subunit 2005.11; 96 (7): 714-716. ( PubMed )

  2. Yoshida Soichiro, Hayashi Tetsuo, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Watanabe Toru, Yamada Takumi: A stage-dependent follow-up strategy after radical cystectomy for bladder carcinoma 2005.11; 51 (11): 727-730. ( PubMed )

  3. Yoshinaga Atsushi, Hayashi Tetsuo, Ohno Rena, Yoshida Soichiro, Ishii Nobuyuki, Terao Toshiya, Watanabe Toru, Yamada Takumi: A case of renal cell carcinoma associated with idiopathic thrombocytopenic purpura 2005.06; 51 (6): 377-380. ( PubMed )

  4. Yoshinaga Atsushi, Hayashi Tetsuo, Ishii Nobuyuki, Yoshida Soichiro, Ohno Rena, Terao Toshiya, Watanabe Toru, Yamada Takumi: A case of spontaneous rupture of infectious renal cyst with difficulty in diagnosis 2005.04; 51 (4): 257-259. ( PubMed )

  5. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi: A case of true ureteral diverticulum 2005.01; 96 (1): 25-28. ( PubMed )

To the head of this page.▲